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Tuberculosis (Tb) is second only to HIV/AIDS as the most fatal disease caused by a 
single infectious agent. Mycobacterium tuberculosis (Mtb) is the causative agent of the 
disease and is an intracellular pathogen that first infects phagocytes in the lungs. To 
successfully establish an infection in the host and setup a replicative niche, the bacteria 
has to be able to evade detection and manipulate innate immune responses in an effort 
to delay induction of inflammation and the subsequent onset of adaptive immunity. The 
investigations in this dissertation are focused on three different innate immune evasion 
mechanisms employed by mycobacteria: (1) inhibition of inflammasome activation (2) 
secretion of virulence factors and (3) inhibition of apoptosis. 
First we demonstrated that unlike the avirulent mycobacterial species, Mtb 
limits the secretion of IL-1β by inhibiting AIM2 inflammasome activation. 
Experiments revealed that Mtb was able to inhibit AIM2 activation and IFN-β 
production induced by M. smegmatis/dsDNA (AIM2 ligand) in an ESX-1 dependent 
manner. Mtb did not affect the expression of AIM2 or IL-1β but rather, inhibited the 
activation of the inflammasome itself as evidenced by a decrease in caspase-1 cleavage. 
In another study, we characterized one of the three gene regions (Rv1037c-Rv1040c) 
  
duplicated from the ESX-5 secretion system for its role in protein secretion, its effects 
on host cell immune responses and its virulence in a zebrafish model. We named this 
four gene region as ESX-5a. Even though the ESX-5a region is required for the 
secretion of Alanine-L dehydrogenase (ALD), it does not contain genes encoding for 
the components of a secretion system. Instead, a western blot analysis of the cell 
supernatants of an ESX-5 system mutant showed that ALD was exported via the parent 
ESX-5 secretion system. The Mtb ESX-5a mutant was found to be defective in inducing 
inflammasome activation and the M. marinum mutant was attenuated in the fish model. 
The final study focuses on screening for anti-apoptotic genes. In vitro infections with 
Mtb transposon mutants helped identify Rv1048c as a novel anti-apoptotic gene. As a 
result, we have identified several novel mechanisms by which Mtb achieves a survival 
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CHAPTER 1: INTRODUCTION 
1.1 Tuberculosis 
Tuberculosis (Tb) still remains one of the biggest global health concerns. The 
2013 global Tb report issued by the World Health Organization (WHO) states that in 
2012 alone, about 8.6 million people were diagnosed with Tb and 1.3 million fatalities 
have occurred, including ~0.3 million deaths among HIV positive people. Tb is a 




Tb is one of the oldest known diseases afflicting humans, since  the first infected 
specimen excavated from the Mediterranean Sea was dated to be around 9,000 years 
old [105]. However, there is evidence indicating the origin of Mycobacterium 
tuberculosis (Mtb) as a human pathogen occurred over 70,000 years ago. Since then it 
was believed that the organism migrated out of Africa along with the humans and was 
transmitted due to increase in population density [49]. Over the years, Tb has been 
known by other names such as consumption, white plague, phthisis etc. In the absence 
of any knowledge about cause or treatment regimens, Tb was the leading cause of death 
in 17th century Europe owing to poor sanitation and over-crowded cities which created 
ideal environment for rapid spread of Mtb [15]. It was only since the early 19th century 
that the details about the cause and transmissible nature of the disease arose, but the 
only treatment options available were rest and retreat to cold climates. The first cure 
for Tb was found only in the mid-20th century with the discovery of streptomycin by 
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Selman Waksman [57]. Many notable people, namely – Frederic Chopin, John Keats, 
Eleanor Roosevelt, Thoreau and Voltaire succumbed to the disease.  
 
1.1.2 Causative Agent 
The causative agent of Tb is Mycobacterium tuberculosis (Mtb). This organism 
belongs to a group of closely related members called the M. tuberculosis complex. They 
are known to cause Tb in humans (Mtb, M. africanum etc) and animals (M. bovis, M. 
microti etc) [36]. Other mycobacterial species found in the environment such as M. 
avium and M. kansasii, cause lung infections similar to Tb in immunocompromised 
people and are classified as non-tuberculous mycobacteria (NTM) [206]. Mtb is a 
facultative, intracellular pathogen that exclusively resides and persists within a human 
host. Mycobacterial species have a unique membrane composition made up of lipids 
called mycolic acid forming the “mycomembrane” that contributes to its unusual 
properties [169]. They are weakly Gram positive but identified by acid fast staining 
techniques such as Ziehl-Neelsen stain. The virulent mycobacterial species are also 
extremely slow growing with a doubling time of ~24 hours. 
 
1.1.3 Disease Progression 
Mtb is spread directly from person to person through aerosol droplets released 
from active Tb patients through coughing or sneezing. They are highly infectious with 
1-2 bacilli being enough to mount an infection [168]. Upon entry into the lungs, Mtb 
first encounters the alveolar macrophages and is phagocytized by them. They can also 





Figure 1: Bacterial fate after infection [adapted from 64].  
Bacteria are engulfed by phagocytes upon inhalation and can meet with three fates: clearance, 




Upon entry and phagocytosis, Mtb can: 1) be cleared by the immune system 
2) disseminate causing active disease or 3) establish a latent infection (Fig 1).  
Mtb can cause an active disease in immunocompromised individuals, patients taking 
immunosuppressive drugs and people suffering from malnutrition or old age. Here the 
bacteria induce necrosis, a form of cell death that induces membrane lysis that does not 
affect its viability [61]. Upon release, the bacteria can re-infect neighboring cells 
causing disease dissemination. In the case of latent infection, the bacteria remain 
dormant. Additionally, the infected macrophages secrete cytokines and chemokines to 
recruit other immune cells to the site of infection. The bacteria are walled off within a 
structure called the granuloma, which is an organized collection of immune cells. The 
granuloma consists of infected macrophages in the center surrounded by macrophages 
that fuse to form giant multinucleated cells (MGC) or differentiate in lipid rich foamy 
macrophages (FM). The outer rim of the granuloma is made up og T and B 
lymphocytes. The bacteria contained within this structure remain in a dormant non-
replicative state [72]. However, they can re-activate at any time during the life of the 
infected individual owing to a variety of host factors such as malnutrition, old age and 
HIV infection. During such time, the center of the granuloma undergoes necrosis 
(forming a caseum), ultimately causing the disintegration of the entire structure and 
dissemination of the bacteria (Fig 2) [39]. 
 
1.1.4 Epidemiology 
One-third of the world is latently infected with Tb, with the highest incidences seen in 




Figure 2: Formation of the granuloma [204]. 
The figure describes the steps leading to formation of granuloma leading to latency and escape 




A properly functioning immune system is imperative for controlling the disease, which 
is why the resurgence of Tb is closely tied to the high HIV infection rates [16]. 
However, the rates of new Tb cases have been decreasing over the past few years due 
to the efforts of various organizations to diagnose and treat both diseases (WHO 2013 
Factsheet). About 90% of the affected individuals do not develop the active form of 
infection, a condition referred to as latent Tb. During this time the infected people are 
asymptomatic and non-contagious. However, the dormant bacteria can reactivate at any 
time and cause an active infection. The infected individuals then display the following 
symptoms: fever, night sweats, weight loss, chest pain and a chronic cough resulting in 
bloody discharge of sputum [68].  
 
1.1.5 Treatment and Prevention 
The development of Tb therapy began in 1882 when Robert Koch identified 
Mtb as the causative agent of the disease.  The discovery of X-rays by Roentgen made 
tracking the disease progression easier. However, the only treatment options available 
during this period were fresh air, rest and a good diet. The afflicted people were sent to 
places called “sanatoriums” where they were quarantined until they succumbed to the 
disease. The first concrete step in treating Tb was the discovery of streptomycin by 
Selman Waksman and Albert Schatz (1943). Shortly after, there were a barrage of drugs 
discovered, namely, isoniazid, rifampin, pyrazinamide and ethambutol which formed 
the first line antibiotics [198]. Even today, all four of these drugs are prescribed as a 
combination chemotherapy that typically lasts 6-9 months. Isoniazid is highly toxic and 
can cause neuropathy, which is why it is given along with pyridoxal phosphate or 
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vitamin B6 to prevent nerve damage. These drugs are to be taken for 4 months after 
which only isoniazid and ethambutol are taken for 2 additional months. All of these 
drugs have different modes of action against Mtb; for example, inhibiting cell wall 
synthesis (isoniazid) or transcription (rifampin) (Fig 3) [194]. 
The above regimen is good only for drug susceptible Mtb. In many cases 
patients do not complete the full antibiotic course because the regimen is too long or 
that they start feeling better after a few weeks. This led to the development of drug 
resistant strains and disease relapse, in which case the second and third line antibiotics 
are used [190]. The second line drugs include flouroquinolones, aminoglycosides and 
cyclosporine among others. These drugs are known to cause more severe side effects 
or in some cases are expensive and not readily available. The multi-drug resistant 
(MDR) strain of Mtb is found to be resistant to both isoniazid and rifampin [174]. 
However, ineffective chemotherapy with the second line drugs led to development of 
extremely drug resistant (XDR) strain in the early 2000s. The XDR strain is resistant 
to isoniazid, rifampin, second line drugs such as flouroquinolones and at least three 
injectable drugs (amikacin, kanamycin and capreomycin) leaving patients with very 
few treatment options [42].  
Albert Calmette and Camille Guerin generated the vaccine M. bovis BCG after 
passaging M. bovis for 11 years and the BCG vaccine was first administered in 1921 







Figure 3: Mechanisms of action of first line antibiotics against Mtb (NIAID).  
Both isoniazid and ethambutol inhibit cell wall synthesis. Pyrazinamide disrupts energy 





However, use of the BCG vaccine has been decreasing over the years because of its 
variable efficacy in protecting adults from pulmonary Tb (0-80%), which is in part 
based on the specific vaccine strain used and the geographical location [47, 80]. 
Another drawback of BCG is that it poorly stimulates CD8 T-cells to mount a robust 
adaptive immune response [31, 187]. 
 
1.2 Mycobacteria and Immune Response 
Immune response (IR) against invasion by a pathogen can be classified into two 
distinct types: 1) Innate Immunity and 2) Adaptive Immunity. 
Innate immunity is a primary response mediated by detection of pathogen 
associated molecular patterns (PAMPs) leading to a localized inflammatory response 
to recruit other immune cells to the site of infection. Its functions include signaling 
events leading to the destruction of the pathogen as well as processing antigens to 
stimulate the second IR, which is adaptive immunity. When compared to innate IR, the 
adaptive response is more specific leading to cellular and humoral immunity and also 
results in long term memory. Some of the components and signaling processes required 
for mediating a successful immune response against Mtb are listed below. 
 
1.2.1 Detection of Mtb 
Innate IR involves the detection of Mtb by a host of cell types such as 
macrophages, dendritic cells (DC) etc., which are then capable of ingesting the bacteria. 
Multiple Mtb ligands are recognized by various receptors such as Toll Like Receptor 2 
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(TLR2) in cooperation with dectin-1 [239], DC specific intracellular adhesion molecule 
3 grabbing non-integrin (DC-SIGN), Mannose Receptor (MR) and Complement 
Receptor CR3 displayed by the alveolar macrophages before being phagocytized [74, 
220]. The uptake of Mtb by DCs is primarily mediated by DC-SIGN [94]. 
The TLRs are a family of membrane bound pattern recognition receptors 
(PRRs) that detect microbial ligands and activate inflammatory pathways as a result 
[9]. Downstream signaling of TLR-ligand binding leads to activation of various 
transcription factors like NF-κB and AP-1, which in turn induce the transcription of 
various inflammatory cytokines. In vitro infections with Mtb show that TLR2 plays a 
very important role as it detects lipopeptides when associated with TLR1 and TLR6. A 
mycobacterial protein called the 19 kDa lipoprotein is recognized by TLR2/1 [222], 
while an extract of Mtb called soluble Tb factor is detected by TLR2/6 [38]. Deletion 
of TLR9 in DCs caused a partial reduction in IL12p40 production and while a 
TLR2/TLR9 double deletion completely abrogated IL12p40 secretion [155]. The above 
data demonstrates that TLR9 has a role to play in Mtb infection control. The individual 
role of TLRs in vivo has been difficult to show because of redundancy and many 
conflicting reports [71, 188]. However, the deletion of multiple TLRs increases 
susceptibility to infection in mice. 
Nucleotide-binding oligomerization domain-like receptors (NLR) are a family 
of cytoplasmic receptors that interact with PAMPs or danger associated molecular 
patterns (DAMPs) within the cell and are shown to be very important for innate 
immunity against Mtb. These proteins contain 3 major domains: (1) a central nucleotide 
binding domain, (2) a C-terminal ligand binding domain and a (3) a variable N-terminal 
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domain involved in protein-protein interactions. The N-terminal domain is usually a 
caspase recruitment domain (CARD) or pyrin domain (PYD) [86]. One of the major 
consequences of NLR ligation is the formation of a multi-protein complex called the 
inflammasome, which leads to various cellular effects such as cell death by pyroptosis 
and maturation of the inflammatory cytokines: Interleukin 1β (IL-1β) and Interleukin 
18 (IL-18). There are many NLRs activated upon bacterial infection as discussed 
below. Of these, multiple studies have shown that Mtb infection solely activates the 
NLRP3 inflammasome [1, 128, 153]. Absent in melanoma 2 (AIM2) is a member of a 
family of receptors called the AIM2 like receptors (ALRs) that can also activate the 
inflammasome after binding to double stranded DNA (dsDNA) [76, 191]. Thus, the 
initiation of immunity against the pathogen starts with detecting different pathogenic 
components via various cellular receptors. 
 
1.2.2 Cytokines 
Cytokines are signaling proteins secreted by cells to shape the immune 
response. They have multiple roles in immune response, such as maturation of immune 
cells, initiating either cell mediated or humoral response and recruitment of other 
immune cells to the site of infection. Cytokines involved in cell recruitment to the site 
of infection are called chemokines. The cytokines shown to be most important for 
controlling Mtb infection are Tumor Necrosis Factor (TNF), Interferon gamma (IFNγ), 
Interleukin 12 (IL-12) and IL-1β, all of which are pro-inflammatory in nature.  
TNF produced by macrophages and T-cells is important for macrophage 
activation. It also has an important role of inducing apoptotic cell death in infected 
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macrophages [160]. It helps in maintaining the structure of granuloma as both TNF and 
TNF receptor (TNFR) knockout mice are highly susceptible to Mtb infection and show 
impaired granuloma formation [17,84]. Studies involving M. marinum infected 
zebrafish showed that in the absence of TNF, the granulomas had highly necrotic 
centers and disintegrated more rapidly [182]. This phenotype of high susceptibility is 
also reflected in humans who are being treated with TNF inhibitors [124]. In a macaque 
model, the addition of TNF-neutralizing antibodies caused the animals with latent 
infection to rapidly developed active Tb [136].  
IL-12 is mainly secreted by macrophages, DCs and neutrophils in response to 
ligation of TLR-9 and TLR-2 [11]. It plays an important role in T-cell differentiation 
into TH1 (T Helper1) type IR which is important for controlling intracellular pathogens 
[52, 171, 226]. Mice deficient in IL-12p40 and IL-12p35 are highly susceptible to Mtb 
infections [127]. As a result of TH1 response, IFNγ is produced by CD4 and CD8 T-
cells. This cytokine is essential to Mtb infection control as it induces the production of 
inducible nitric acid synthase (iNOS) in macrophages that is required for 
mycobactericidal effects and in its absence there is increased dissemination of the 
pathogen within the mouse [51]. 
 
IL-1β 
IL-1β is another important cytokine required for the control of Mtb infections. 
The absence of IL-1β or its receptor causes mice to succumb within 40 days of an Mtb 
challenge while the infected WT mice survive for more than a year [89, 153]. IL-1β is 
highly pro-inflammatory, thus the production of mature IL-1β is a tightly regulated 
two-step process. It is produced as an inactive precursor that must undergo cleavage to 
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form a mature 17 kDa fragment that is then secreted outside the cell. Another layer of 
regulation comes in the form of decoy receptors and IL-1R antagonists, which disrupt 
the IL-1β/IL-1R interaction [65]. Even though most in vitro studies show that IL-1β 
secretion is inflammasome mediated, in vivo IL-1β can be cleaved by caspase-1 
independent mechanisms [153] and this process is shown to occur in neutrophils with 
the help of cathepsins and elastases [99]. IL-1β is directly involved in killing of 
mycobacteria as it is required for up-regulation of TNF secretion and increased 
caspase-3 activation [116]. Autophagy is considered to be an anti-inflammatory 
cellular process that inhibits inflammasome components and thus limits IL-1β 
production. However, a recent study has described a new role for IL-1β signaling 
mediated autophagic response that is required for killing mycobacteria in a TANK 
binding kinase-1 (TBK-1) dependent manner [178]. The process of generating the 
mature cytokine is by the activation of an inflammasome and is described below. 
 
Inflammasome Activation 
Firstly, inactive pro-IL-1β and pro-IL-18 are produced due to TLR ligation with 
bacterial products (signal 1) leading to NF-κB dependent transcription of il1β and il18. 
This pro form of IL-1β needs to be cleaved before it can be secreted and initiate its 
signaling events via the IL1 receptor (IL1R). Therefore, the second step involves the 
formation of a multi-protein complex called the inflammasome, which is initiated by 
the NLR binding to a PAMP/DAMP (signal 2) [148].  
Some of the PAMPs recognized by various NLRs are: flagellin (NLRC4) [85] 
and anthrax lethal toxin (NLRP1) [30]. Recent studies have shown that NLRP3 does 
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not directly bind to a ligand, but various cellular insults result in potassium depletion 
of the cytosol that in turn leads to its activation. Some of the other known effectors are 
ATP, alum, cholera toxins etc. [165]. The inflammasome can also be activated by 
AIM2. The inflammasome consists of activated NLR bound to the Apoptosis 
associated Speck-like protein containing a CARD (ASC) protein via its pyrin domain. 
The ASC protein binds to pro-caspase-1via the CARD region. However, not all NLRs 
require the adaptor protein ASC (e.g. NLRC4) as they can directly recruit caspase-1. 
The oligomerization of caspase-1 results in auto-proteolytic cleavage to release 
activated caspase-1. This cleaved caspase-1 in turn cleaves pro- IL-1β and pro-IL-18 
into mature IL-1β and IL-18, respectively (Fig 4). Thus, the inflammasome activation 
is critical for the maturation of IL-1β and IL-18. 
 
1.2.3 Innate Immune Cell Types 
Phagocytes are important for mounting an innate IR against Mtb. Once the 
pathogen is internalized, macrophages unleash a host pathogen killing mechanisms 
such as production of reactive oxygen species (ROS) and reactive nitrogen 
intermediates (RNI), anti-bacterial peptides, maturation of phagosome resulting in 
phagolysosome fusion and degradation of bacterial cell wall by lysosomal hydrolases 
[reviewed in 161]. Additionally, the cells undergo apoptotic cell death (discussed 
below) to prevent bacterial escape. The bacteria are killed by a process called 
efferocytosis which involves the uptake of bacteria-containing apoptotic bodies by 
neighboring phagocytes. The apoptotic bodies are also phagocytized by DCs which in 




Figure 4: IL-1β secretion by NLRP3 inflammasome activation.  
Maturation of IL-1β and IL-18 is a two-step process involving the transcription of cytokine 





Neutrophils are phagocytic cells that quickly migrate to the site of infection in 
response to chemokines secreted by activated macrophages. These cells contribute to 
early defense by inducing a strong respiratory burst (influx of ROS into the phagosome) 
and by producing “defensins”, enzymes known to kill mycobacteria [150]. The 
neutrophils are short lived as they rapidly undergo apoptosis and the apoptotic blebs 
are engulfed by DCs. DCs acquiring Mtb infected neutrophilic apoptotic bodies are 
better at migrating to lymph nodes and activating CD4 T-cells to mount an adaptive IR 
when compared to DCs that directly acquired Mtb [27]. 
While macrophages and neutrophils are major mediators of innate immunity, 
DCs are the most potent antigen presenting cells (APCs) that act as a bridge between 
the innate and adaptive IR. Immature DCs present in the lungs either directly 
phagocytize invading bacteria or the remnants of infected macrophage/neutrophils 
apoptotic bodies. As a result, the DCs mature and migrate to the lymph nodes where 
they process the bacterial antigens via MHC class I and II molecules and present the 
processed peptides to prime naïve T-cells [12,158]. 
 
 Apoptosis – Mechanism and Characteristics 
Cell death by apoptosis is one of the mechanisms of innate IR initiated by 
macrophages upon infection. Apoptosis is a process of programmed cell death, wherein 
a cell on receiving specific stimuli undergoes a series of orderly steps that ultimately 
leads to its demise. Apoptosis is very important for embryonic development, selection 
of leukocytes, general homeostasis and host defense [73]. Cells undergoing this form 
of cell death show signs of shrinkage due to their cytoskeleton breakdown. Other 
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hallmark features are membrane blebbing, DNA condensation and fragmentation. The 
flipping of inner cell membrane to the outside causes the exposure of 
phosphatidylserine and this is an early stage marker of apoptosis. However, unlike in 
necrosis, the caustic cell contents are not spilt into the extracellular milieu but contained 
within an impermeable “apoptotic envelope” [179]. With time, the cell breaks into 
smaller vesicles called “apoptotic bodies” which are then phagocytized by the 
surrounding cells before they can cause any damage. Hence, this form of cell death is 
immunologically silent. Apoptosis is mediated by a group of cysteine-aspartic 
proteases called caspases via two different pathways: intrinsic or extrinsic pathways 
[73] (Fig 5). 
 
Intrinsic Pathway of Apoptosis 
The intrinsic pathway is generally activated in response to cell damage by 
toxins, free radicals, radiation or DNA damage and involves the mitochondria [73]. 
Under normal conditions, the mitochondrial membrane is coated by anti-apoptotic 
proteins of the Bcl-2 family. These proteins bind to and sequester the pro-apoptotic 
proteins of the Bcl-2 family. All members of this family consist of homology domains 
called BH1-BH4. Anti-apoptotic members have all four domains while pro-apoptotic 
members may either have all domains or only the BH3 domain. Stress creates an 
imbalance between the two factions of this family and this leads to mitochondrial outer 
membrane permeabilization (MOMP) [8]. As a consequence, cytochrome c is released 
into the cytoplasm. This leads to the association of cytochrome c with apoptosis 




Figure 5: Schematics of apoptotic pathways [adapted from 237]. 
The figure describes the steps involved in both extrinsic and intrinsic pathways of apoptosis 




The Apaf-1 binds to the (initiator) pro-caspase-9 through its CARD and 
activates it, thus forming a complex of proteins called the apoptosome. The activated 
caspase-9 is released and activates the effector caspase-3 [189]. The activated caspase-
3 in turn cleaves the inhibitor ICAD/DFF-45 to allow the endonuclease activity of CAD 
leading to DNA fragmentation [137] (Fig 5). 
 
Extrinsic Pathway of Apoptosis: 
The extrinsic pathway is induced by external signals such as binding of specific 
ligands to the Tumour Necrosis Factor Receptor 1 (TNFR1) and Fas [232]. The next 
step in this signaling cascade is the recruitment of death domains. During a Fas ligand- 
Fas interaction, the Fas associated death domain (FADD) binds to the cytoplasmic tail 
of the receptor. In case of TNF-TNFR association, TNF receptor associated death 
domain (TRADD) is recruited, which in turn recruits the FADD protein. Caspase-8 and 
10 (also called initiator caspases) can now bind to FADD protein. This complex is 
referred to as the death inducing signaling complex (DISC). The pro-caspases are now 
cleaved into their active form. From this point onwards the pathway can proceed two 
ways. The activated caspase-8 cleaves the pro-caspase-3 (effector caspase) into its 
active form or it cleaves the protein BID into tBID (truncated), which then intertwines 
with the intrinsic pathway by associating with other Bcl-2 family members on the 
mitochondrial surface and causing MOMP [134, 139] (Fig 5).  
Apoptotic death of infected macrophages not only affects bacterial viability but 
it is also important for mediating cross presentation by DCs to naïve T-cells to initiate 
an adaptive IR. 
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1.2.4 Adaptive Immune Response 
The adaptive immune response is the secondary response generated by the host 
immune system against foreign invasion. The T and B lymphocytes initiate a highly 
specific immune response that is tailor-made against the invading pathogen. B cells 
mount a humoral response by generating antibodies. T-cells are activated by processed 
antigens presented to it by APCs and mount a cell mediated IR. T-cells form two 
distinct populations: T Helper cells (CD4+) and cytotoxic T-cells (CD8+). Depending 
on the cytokine secreted, the CD4 cells can induce either an inflammatory TH1 
response or an anti-inflammatory TH2 response. Macrophages and dendritic cells 
secrete IL-12 to push the CD4 cells toward a TH1 type response. Once stimulated, the 
CD4 T-cells can now produce IFNγ, IL-2 and TNF, which are known to activate 
macrophages and make them more efficient at killing pathogens [82]. Cytotoxic or CD8 
T-cells are mostly activated by cross-presentation pathways involving DCs. The 
activated CD8 T-cells secrete IFNγ, perforins and granulysins that can lyse host cells 
and kill bacteria directly [214].The importance of the CD4 T-cell population during 
Mtb infections is evidenced by the finding that people with very low CD4 T-cell counts 
(HIV patients) show increased susceptibility to active Tb [200]. The macrophages and 
neutrophil apoptotic bodies containing Mtb and its antigens are phagocytized by DCs, 
which then process the mycobacterial antigens via MHC class I molecules and present 
them to naïve CD8 T-cells to activate them [67, 235]. Both the T-cell populations are 
also very important for granuloma formation and the absence of either one or both 
lineages make mice highly susceptible to Tb [82]. Thus, adaptive IR is very important 
for the control of mycobacterial infections. 
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1.3 Mtb Evasion of Host Immune Responses 
Mtb successfully persists within a macrophage phagosome, which by nature is 
a harsh environment. To survive, it uses various strategies to avoid being detected and 
killed by the immune cells. Some of the immune evasion mechanisms employed by 
Mtb are listed below. 
 
1.3.1 Secretion of Virulence Factors 
Mtb has a specialized protein secretion system referred to as the Type VII 
secretion system (T7SS), which encompasses five individual systems of similar gene 
groups labeled as ESX 1-5. All of these systems contain the usual elements of a 
secretory system, such as: a transmembrane protein acting as a channel and an ATPase. 
Additionally, the T7SS encode for two small, secreted proteins belonging to the ESAT6 
family and are flanked by pe and ppe genes (except in ESX-4). The group of proteins 
belonging to a family called PE or PPE, are exclusive to the mycobacterial genus and 
found encoded by the genome of slow growing mycobacteria only. The PE/PPE protein 
families derive their names from the Pro-Glu (PE) and Pro-Pro-Glu (PPE) motifs found 
in the N-terminal of these proteins. Of the 5 T7SSs, both ESX 1 and ESX 5 are 
important for virulence in Mtb [4, 29, 180].  
EsxA (a member of the ESAT6 family) is secreted by the ESX-1 system and is 
required for multiple processes such as, co-dependent secretion of other virulence 
factors, perforating the phagosomal membrane [209] and abrogating NF-κB activity by 
directly binding to and inhibiting TLR2 function [176]. EsxH and EsxG are the ESAT6 
family proteins contained in and secreted by the ESX-3 system. The ESX-3 system is 
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involved in the secretion of proteins involved in iron and zinc uptake [201]. These 
proteins directly bind to components of the endosomal sorting complex required for 
transport (ESCRT) pathway and impair phagosome maturation [156]. The ESX-5 
system is required for the secretion of various members of the PE/PPE family. Single 
gene deletion mutants of ESX-5 components or their secreted proteins are attenuated 
during mouse infections [29, 197]. Due to the sheer number of PE/PPE proteins, it is 
difficult to tease out individual functions, but the current hypothesis is that these 
proteins interact with a variety of host components and aid in immune evasion. In fact, 
members of the PE/PPE family are involved in modulating host responses by 
interacting with TLR2 [13,167], preventing vacuole acidification [117, 215] and 
limiting antigen presentation [32]. 
 
1.3.2 Inhibition of Phagolysosome Fusion 
When a macrophage engulfs a foreign particle, the phagosome undergoes a 
series of maturation events by fusing with the early and late endosomes and finally 
fuses with the lysosomes. The lysosome is a storehouse of various hydrolytic enzymes 
that can digest the foreign bodies. Through various stages of maturation the phagosome 
acquires various markers that direct its fusion with other vesicles. The interior of the 
phagolysosome becomes increasingly acidic due to the recruitment of the vacuolar 
proton ATPase and this activates the lysosomal hydrolases [161].  
Virulent Mtb strains have developed the means to prevent the acidification of 
the vacuole and hence can arrest phagosome maturation [217]. Mtb containing 
phagosomes are also found to be coated with tryptophan-aspartate containing coat 
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(TACO) protein, which prevents it from fusing with the lysosome [78]. Release of Ca2+ 
from intracellular stores to increase its cytosolic concentration is required for the 
membrane fusion between two vesicles. However, the lipoprotein Man-Lam (Mannose 
capped Lipoarabinomannan), found only in pathogenic Mtb, is able to inhibit the 
increase in Ca2+ concentrations and its downstream signaling [192]. Other 
mycobacterial lipids such as trehalose dimycolate [113] and proteins like SapM [231] 
and PknG [233] have also been implicated in prevention of phagolysosome fusion. 
 
1.3.3 Inhibition of ROS and RNI 
Activated macrophages and neutrophils can efficiently kill microbes through 
the generation of ROS and RNI. ROS is generated by the assembly of the NOX2 
complex on the phagosome membrane. The process of NOX2 activation is very tightly 
regulated and requires the assembly of several proteins on the cytoplasmic side. Once 
active, it can transfer electrons across the membrane to generate superoxides [19]. The 
generated ROS, is not only highly toxic but also plays additional roles in cell signaling. 
ROS production affects the activation of Ask-1 (a member of the mitogen activated 
protein kinase- MAP3K family) which in turn activates Jun N-terminal kinase (JNK) 
and p38 pathways.  Both JNK and p38 are involved in induction of apoptosis [112, 
221]. ROS is also required for TNF synthesis by macrophages, which is absolutely 
necessary for apoptosis induction and controlling Mtb growth [160]. Thus, Mtb have 
evolved ways to neutralize the effect of ROS by secreting superoxide dismutase A 
(SodA) via the SecA2 secretion system. Thus, deleting the secA2 gene also resulted in 
increased ROS, apoptosis and mycobacterial killing [106]. A mycobacterial gene, 
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nuoG encodes for a subunit of type- I NADH dehydrogenase and is involved in 
mitigating ROS production in Mtb infected macrophages [160]. 
Nitric Oxide (NO) and other reactive intermediates are generated by the enzyme 
called inducible nitric oxide synthase (iNOS). Since the RNI produced are highly 
reactive, proximity to the target is very important and so the iNOS is recruited to the 
bacteria containing phagosome by the actin cytoskeleton [60,159]. The importance of 
RNI activity is evidenced when the mice with the deletion of iNOS succumb to an Mtb 
challenge faster than WT mice. However, the importance of iNOS in controlling 
mycobacterial infections is still a point of contention in humans [140]. Two Mtb 
proteins associated with proteasome functions, Mpa and PafA, are important for NO 
detoxification [58, 59], but their exact mechanism of action is still unknown. Mtb also 
interferes with the process of iNOS recruitment to the phagosome by preventing the 
interaction between iNOS, a scaffolding protein called EBP50 and the actin filament, 
thus reducing the toxic effect of RNI. The Mtb effectors that prevent iNOS recruitment 
are unknown [60, 159]. Thus, Mtb has developed multiple mechanisms by which it can 
neutralize the deleterious effects of both ROS and RNI. 
 
1.3.4 Inhibition of Inflammasome Activation 
NLR family proteins scavenge the cytosol for PAMPs and DAMPs. Upon 
detection of pathogens, they induce inflammatory cascades which eventually lead to 
the onset of innate IR. The main components of the inflammasome are: NLRs, ASC 
and pro-caspase-1. The inflammasome activation leads to production of active caspase-
1. This protease functions to induce a form of cell death called pyroptosis which helps 
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in restricting the growth of intracellular pathogens. Another study shows that, caspase-
1 activates lipid metabolic pathways for repairing the membrane damaged by toxins 
[103]. However, one of the major functions of active caspase-1 is to convert the inactive 
pro forms of IL-1β, IL-18 and IL-33 to their mature forms. There are many means by 
which several pathogens subvert inflammasome activation. The Yersinia effector, 
YopK is secreted into the host cytosol and interacts with the Type III secreted proteins, 
thereby preventing their recognition by NLRs [35]. Another Yersinia protein, YopM 
directly binds to pro-caspase-1 active site and prevents its recruitment to the 
inflammasome [130]. Legionella inhibits the transcription of the adaptor protein ASC, 
thereby mitigating the secretion of IL-1β [7]. The secreted effectors of P.aeruginosa, 
EsxoU and ExoS suppress NLRC4 inflammasome activation by an unknown 
mechanism [90, 218]. Other bacteria such as Salmonella, Chlamydia and Francisella 
also evade inflammasome activation [53]. 
The importance of IL-1β in controlling Mtb infections is quite evident from in 
vivo survival studies using IL-1β-/- mice that die within 4 weeks of being infected with 
Mtb [153]. Most in vitro infections of macrophages and DCs show NLRP3 to be the 
sole NLR to be activated by Mtb as infected NLRP3 knockout macrophages do not 
secrete any IL-1β [1, 41, 153, 162]. During Mtb infections, IFNγ produced by CD4 
cells results in the increased NO levels. NLRP3 undergoes S-nitrosylation directly by 
NO, resulting in the inhibition of inflammasome activation [163]. It has also been 
shown that Mtb inhibits NLRP3 inflammasome via IFNβ mediated induction of anti-
inflammatory IL-10. The IL-10 signaling then leads to suppression of proIL-1β 
expression [152, 170]. One report has shown that AIM2 deletion in mice caused 
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increased susceptibility to Mtb infection [195]. Considering that no activation of AIM2 
is seen in cells infected with Mtb, it gives rise to the possibility that Mtb could also 
inhibit the AIM2 inflammasome.  
 
1.3.5 Inhibition of Apoptosis Induction 
Induction of apoptosis in infected cells is an important innate defense 
mechanism employed by phagocytes to restrict bacterial growth via a process called 
efferocytosis. This process is described as the uptake of apoptotic bodies by 
neighboring phagocytes (described in section 4.1.2) and as a result can stimulate 
adaptive immunity. However, induction of host cell apoptosis would be detrimental to 
Mtb survival and it employs multiple strategies to manipulate cell death pathways to its 
advantage. 
Virulent Mtb strains can inhibit apoptosis and subsequently push the cell 
towards a more necrotic form of cell death while avirulent strains are unable to evade 
killing by apoptosis (Fig 6). Necrosis allows the bacteria to be released into the 
extracellular milieu unharmed and gives them the opportunity to re-infect neighboring 
cells, thus causing spread of infection [123, 179]. Virulent Mtb inhibit apoptosis by 
enhancing the release of soluble TNFR2 factors by the cell and the subsequent 
neutralization of TNF [87]. Upon infection, it also reduces the surface expression of 
Fas receptors abrogating the Fas mediated extrinsic apoptotic pathway [172]. Mtb can 
also inhibit intrinsic apoptotic pathways by modulating the expression of various pro- 
and anti-apoptotic proteins of the BCL-2 family. It up-regulates an anti-apoptotic gene 




Figure 6: Cell death modality induced by virulent and avirulent Mtb strains 
[adapted from 179]. 
Avirulent strain of Mtb (H37Ra) induces apoptosis in infected cells while virulent Mtb (H37Rv) 




Another study shows that only virulent Mtb can up-regulate the anti-apoptotic protein, 
Bcl-w [210] while the pro-apoptotic Bad is inactivated upon infection [141]. More 
recently, it was shown that macrophages infected with an avirulent Mtb strain (H37Ra) 
underwent apoptosis and this process involved the formation of an “apoptotic 
envelope”. The process begins with the exposure of phosphatidylserine on the cell 
surface and the deposition of phospholipid binding protein, annexin-1. The next step is 
the cross-linking at the amino terminal of annexin-1 to complete the apoptotic 
envelope. In case of virulent Mtb (H37Rv) infected cells, the amino terminal of 
annexin-1 was cleaved by proteolysis preventing the cross-linking and hence the 
formation of the envelope. As a result, the cells could not undergo apoptosis [91]. 
Another report shows that eicosanoid biosynthetic pathways are involved in selecting 
cell death modality. Membrane phospholipids when acted upon by cytosolic 
phospholipase A2 produce arachidonic acid (AA). This is the precursor for multiple 
prostaglandins (PG) and lipoxins (LX). Avirulent Mtb induces the conversion of AA to 
prostaglandin E2 (PGE2) by cyclooxygenase 2 (COX2). When PGE2 interacts with 
receptors EP2 and EP4, they prevent damage specifically to the mitochondrial inner 
membrane and promote lysosome-mediated plasma membrane repair, ultimately 
leading to apoptosis (Fig 3). PGE2 is involved in synthesis of plasminogen activator 
inhibitor type 2 (serpin B2 protease inhibitor), which blocks the cleavage of annexin-1 
amino terminal. It is also induces the transcription of synanptotagmin-7 (syt-7), a Ca++ 
sensor that allows for lysosomal repair of the plasma membrane. H37Rv instead, 
induces the conversion of AA into LXA4 through 5-lipooxygenase (5-LO), which 
inhibits the activity of COX2 leading to mitochondrial inner membrane damage, 
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prevention of plasma membrane repair and finally, death by necrosis to allow for 
bacterial dissemination [21,44, 66] (Fig 7).   
 
1.4 Summary and Significance 
The scope of Mtb infection worldwide is staggering. With the emergence of 
HIV and drug resistant strains, the existing treatment and preventative measures are 
outdated and incapable of combating Tb. Current research is again focused on finding 
new antibiotics and vaccines. Therefore, to be able to engineer new therapeutics, it is 
imperative that we improve our understanding of the host-pathogen interactions 
occurring during active and latent infections. With the knowledge of host immune 
responses and counter measures employed by the bacteria we can identify new targets 
for drug design and vaccine strategies. For example, knowing that inhibition of 
apoptosis delays the onset of adaptive immunity, deletion of various anti-apoptotic 
genes alone or in combination, can lead to development of better vaccine strains. The 
following chapters describing three studies of different mechanisms by which Mtb 
inhibits innate immune responses has been the focus of my research. In chapter 2 we 
describe a novel mechanism of inflammasome inhibition by Mtb. We show that Mtb 
actively inhibits the activation of the AIM2 inflammasome by secreting an unknown 
factor via the ESX-1 secretion system. In chapter 3, we demonstrate that a duplicated 
ESAT6 region (ESX-5a) of Mtb aids in the export of virulence factors via the parent 
ESX-5 secretion system. We have also shown that the ESX-5a substrates activate the 
inflammasome and are involved in virulence.  Finally in chapter 4, we identified a novel 






Figure 7: Eicosanoid pathways in cell death [adapted from 21]. 









After phagocytosis, Mtb extracellular DNA (eDNA) gains access to the host 
cell cytosol via the ESX-1 secretion system. The mycobacterial eDNA induces host 
cell IFN-β production that then reduces the NLRP3-inflammasome activation to 
minimize IL-1β secretion. However, the cytosolic eDNA of Mtb does not induce 
activation of the AIM2-inflammasome, even though AIM2 recognizes and binds to 
cytosolic DNA. Here we show that in contrast to Mtb, non-virulent M. smegmatis 
(Msme) induces AIM2-inflammasome activation. Importantly, Mtb inhibits the AIM2-
inflammasome activation induced by either infection with Msme or transfection of 
dsDNA in an ESX-1 dependent mechanism. The inhibition did not involve changes in 
AIM2 mRNA or protein levels but led to decreased activation of caspase-1. In 
conclusion, we report a novel immune evasion mechanism of Mtb that involves the 
ESX-1-dependent, direct or indirect, suppression of the host cell AIM2-inflammasome 





2.2.1 Inflammasome Activation by Mtb 
IL-1β is important for host immune defense against Mtb, since several studies 
demonstrated that IL-1β and IL-1-receptor deficient mice are more susceptible to Mtb 
infections [153, 154]. In macrophages and dendritic cells the production of mature IL-
1β is dependent on activation of the inflammasome [199]. The NLR proteins such as 
NLRP3 and NLRC4 are one family of cytosolic receptors, which upon ligand binding 
mediate inflammasome activation. In the case of Mtb the sole NLR capable of inducing 
inflammasome activation is NLRP3 [1, 69, 153, 154, 162, 236].  
The significance of type I IFN signaling for activation of inflammasome 
responses was first reported for Francisella infected macrophages (Fig 8) [104]. 
Nevertheless, during the course of Mtb infections IFN-β has the opposite effect and 
suppresses activation of the NLRP3 inflammasome, suggesting that induction of IFN-
β could correlate with increased virulence [152, 170]. Mice deficient in Interferon 
Regulatory Factor 3 (IRF-3), a major signaling component of the type I IFN host cell 
signaling pathway, are much more resistant to Mtb infections [147]. 
 
2.2.2 Mtb and the AIM2 Inflammasome 
 
The induction of host cell type I IFN signaling after Mtb infection is dependent 
upon the type VII secretion system (ESX-1) mediated translocation of Mtb extracellular 
DNA (eDNA) into the host cell cytosol (Fig 9) [147, 212]. It is confounding that this 
cytosolic Mtb DNA is not recognized by the host cell inflammasome component AIM2 





Figure 8: IFN-β regulation of AIM2 inflammasome in F. tularensis [adapted from 
98]. 
F. tularensis DNA induces the production of IFN-β which upon autocrine signaling through 




intracellular pathogens such as Francisella and Listeria [107, 196]. There is 
evidence that transfected Mtb dsDNA can interact with AIM2 and activate the 









Figure 9: Secretion of Mtb eDNA and IFN-β activation [adapted from 147]. 
Secreted EsxA perforates the phagosomal membrane allowing Mtb eDNA to access the host 






2.3 Materials and Methods  
Cell culture and animals 
C57Bl/6 WT mice were obtained from The Jackson Laboratories. Nlrc4-/-, Nlrp3-/-, Asc-
/-, Nlrp6-/-, Nlrp10-/- mice were provided by Dr. R. Flavell and Millennium 
Pharmaceuticals. Aim2-/- [183] and Aim2/Nlrp3-/- double knockout mice were obtained 
from Dr. K. A. Fitzgerald. The Ifnar1-/- mice from Dr. A. Sher (NIH). IFN-β-/- mice 
were provided by Dr. S. N. Vogel. All studies were approved by the IACUC at the 
University of Maryland and were conducted in accordance with the National Institutes 
of Health Guide. 
 
Bacteria 
M. smegmatis (mc2155), M. tuberculosis H37Rv (ATCC 25618), H37Ra (ATC25177) 
were obtained from Dr. W.R. Jacobs Jr. (AECOM). M. fortuitum (ATCC 6841) and M. 
kansasii strain Hauduroy (ATCC 12478) were obtained from ATCC. Mtb ΔesxA and 
ΔexoU PAK (P. aeruginosa) were kindly provided by Dr. L. Gao and Dr. V. Lee, 
respectively. M. smegmatis Δesx1, ΔeccCb mutant, ΔeccCb complemented strains were 
kind gifts of Dr. K. Derbyshire [81]. F. tularenesis Live Vaccine Strain (LVS) was 
obtained from Dr. Kevin McIver.  
 
Ex vivo infection 
Bacterial infections of BMDCs and BMDMs were performed as described [1, 28]. For 
induction of AIM2 inflammasome, BMDCs were pre-treated with 20ng/ml LPS 
(Invivogen) for 1 hour and then infected with H37Rv for 4 hours. Infected BMDCs 
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were then washed twice with PBS and transfected with 0.5ug/ml poly (dA:dT) (Sigma) 
using Lipofectamine LTX Plus reagent (Invitrogen) for 2 hours. The transfection was 
performed according to the manufacturer’s instructions and the supernatants were 
harvested 2 hours post transfection.  
 
IFN-β Neutralization 
BMDCs from C57Bl/6 mice were treated with anti-IFN-β neutralizing antibody 7F-D3 
(5 μg/ml) (Abcam) for 1 hour and infected with M. smegmatis at MOI 10:1 for two 
hours as previously described. Cells were then washed with PBS and incubated for an 
additional 20 h in DMEM chase media. Supernatants were collected for ELISA. 
 
Cell death assays   
The adenylate kinase (AK) release assay, Toxilight®BioAssay (Lonza) was used to 
quantify necrotic cell death. The assay was performed according to the manufacturer’s 
instructions.  
 
Cytokine Measurement and Immunoblotting  
ELISA was used to measure secreted IL-1β (BD Biosciences) and IFN-β LEGEND 
MAX™ (BioLegend) respectively. For immunoblotting the cell lysate preparation and 
western blotting was performed as described earlier [1]. The primary antibodies used 
were: anti-IL-1β (R&D systems) at 0.15µg/ml in 0.1% BSA, anti-caspase-1 (Santa 
Cruz) at 1:300, anti-AIM2 (Santa Cruz) at 1:500, anti-Tubulin (Cell Signaling) at 
1:1000. The above 3 antibodies were diluted in 5% milk with TBST. The secondary 
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antibodies used were: Donkey anti-goat (Jackson) at 1:25,000, goat anti-rabbit 
(Jackson) at 1:50,000 and goat anti-mouse (Jackson) at 1:50,000 dilutions respectively. 
 
Real time PCR 
BMDCs were harvested 8 hours post-infection using TRIzol (Invitrogen). Real time 
PCR was done using SYBR green PCR master mix (Roche) with GAPDH as the house 
keeping gene. The primers used were: Aim2: 5’-GTCACCAGTTCCTCAGTTGT-3’ 
and 5’-CACCTCCATTGTCCCTGTTTTAT-3’ Gapdh: 5’- 
ATGGGATTTCCATTGATGACA- 3’ and 5’- CCACCCATGGCAAATTCC-3’; 
Mx1: 5'-TGTGCAGGCACTATGAGGAG-3' and 5'-
ACTCTGGTCCCCAATGACAG-3'; PKR: 5'-GCACCGGGTTTTGTATCGA-3' and 
5'-GGAGCACGAAGTACAAGCGC-3'. 
 
Statistical analysis   
Statistical analysis was performed on at least three independent experiments using 
GraphPad Prism 5.0 software and One-way ANOVA with Tukey’s post-test unless 
otherwise noted in the figure legends. Shown are representative results of triplicate 
values with standard deviation. The range of p-values is indicated as follows: * 




2.4 Results and Discussion 
2.4.1 Non-virulent Mycobacteria Induce AIM2 Inflammasome Activation 
The non-virulent mycobacterial species such as Msme induce a very potent pro-
inflammatory immune response and host cell apoptosis when compared to more 
virulent mycobacterial species [28] but the activation of host cell inflammasome 
mediated by Msme infection has not been analyzed. BMDCs isolated from various 
mouse strains were infected with Msme and the amount of IL-1β in the supernatant was 
detected and normalized to IL-1β levels secreted by WT BMDCs (Fig. 1A). There were 
no differences in cell lysis between UI and infected conditions as determined by AK 
release assay, which showed that the IL-1β present in the supernatant was mainly the 
mature form. Surprisingly, in NLRP3-/- cells the amount of secreted IL-1β dropped by 
less than 50%. This is unexpected because the inflammasome activation in Mtb is 
completely dependent upon the presence of NLRP3 [69, 153, 154, 162]. NLRP6, 
NLRP12, NLRC4, and NLRP10 did not significantly contribute to Msme-induced 
inflammasome activation (Fig 10a). Interestingly however, the deficiency of AIM2, 
resulted in approximately 40% reduction in IL-1 response in BMDCs (Fig 10a) and 
almost 75% reduction in BMDMs (Fig 10b). The partial reductions in IL-1β secretion 
suggested redundancy between AIM2 and NLRP3 pathways. Consistently, the IL-1β 
production in Aim2/Nlrp3-/- cells was further reduced when compared to any of the 
single deletions. However, Msme infected Aim2/Nlrp3-/- BMDCs were still able to 
secrete up to 40% of the IL-1β (Fig 10a). This result suggests that Msme cytosolic 
components are also recognized by one or more unidentified NLRs. The Mtb-induced 





Figure 10:  M. smegmatis (Msme) ESX-1 dependent AIM2 inflammasome 
activation. (a) BMDCs and (b) BMDMs from various indicated knockout mice were 
either left uninfected (UI, grey bars) or infected with Msme (black bars). The cell 
supernatants were harvested 16 hours post infection (hpi) and analyzed for IL-1β 
secretion by ELISA. ***0.0001< p < 0.001, WT (c) BMDCs from WT and Aim2/Nlrp3-
/- mice were infected with different Msme strains (Msme, Δesx1, ΔeccCb, compl) and 
the supernatants were analyzed for IL-1β secretion. Data are shown as the mean and 
standard deviation of triplicate measurements of one representative experiment out of 
three except for 1b and 1c where the data is one representative experiment out of two, 




The core ESX-1 secretion complex is conserved in Msme making it a 
compelling model to study the mechanisms of ESX-1-mediated protein secretion [50, 
173]. Similar to Mtb, a functional Msme ESX-1 secretion system is required for 
AIM2/NLRP3 dependent secretion of IL-1β because two different Msme mutants with 
defective ESX-1 show an almost 50% reduction of IL-1β secretion when compared to 
the WT Msme in WT BMDCs. However, this difference is abolished in Aim2/Nlrp3-/- 
BMDCs (Fig 10c).  
Next, we wanted to investigate if other mycobacterial species activate the AIM2 
inflammasome. We thus infected WT and AIM2-deficient BMDCs with Msme, M. 
fortuitum (Mfort), M. kansasii (Mkan), the attenuated M. tuberculosis H37Ra and the 
virulent M. tuberculosis H37Rv. We monitored IL-1β secretion for all the infections 
(Fig 11a). In general, there was an inverse correlation between virulence of the species 
and the amount of IL-1β induction, with the least virulent species inducing the most 
IL-1β in WT BMDCs (Fig 11a). The infection of AIM2-deficient BMDCs by these 
mycobacterial species allowed us to determine the fraction of total IL-1β secretion that 
was dependent upon presence of AIM2. As expected the Francisella-induced 
inflammasome activation was completely dependent on AIM2, whereas about 40-50% 
of the Msme, Mfort and Mkan induction was dependent on AIM2 (Fig 11a). The 
attenuated Mtb strain H37Ra induced the lowest amount of AIM2 inflammasome 







Figure 11: Non-virulent mycobacteria induce IFN-β dependent AIM2 
inflammasome activation. (a) WT and Aim2-/- BMDCs were infected with Msme, M. 
fortuitum (Mfort), M. kansasii (Mkan), attenuated M. tuberculosis H37Ra and virulent 
M. tuberculosis H37Rv. Francisella Live Vaccine Strain (LVS) infection is used as a 
positive control. The secreted IL-1β was measured at 16hpi by ELISA. (b) IFN-β 
ELISA of supernatants from WT BMDCs infected with indicated mycobacterial 
species. ***0.0001< p < 0.001 Msme (c) IL-1β ELISA of supernatants from WT and 
Aim2-/- Msme infected BMDCs in the presence or absence of IFN-β neutralizing 
antibodies. LVS is used as a positive control. (d)  IL-1β ELISA of supernatants from 
Ifnar1-/- or WT BMDCs infected with Msme or left uninfected. Data is shown as the 
mean and standard deviation of triplicate measurements of one representative 




2.4.2 Non-virulent Mycobacteria Induce IFN-β Dependent AIM2 Inflammasome 
Activation 
The AIM2 inflammasome activation by Francisella is stimulated by IFN-β 
[104]. In order to investigate the potential importance of IFN-β in AIM2-
inflammasome activation by non-virulent mycobacteria we analyzed the supernatants 
of BMDCs infected with various mycobacterial species for IFN-β production. 
Interestingly, the three species (Msme, Mfort and Mkan) that mediated the strongest 
AIM2-inflammasome activation also induced a very pronounced IFN-β production of 
approximately 800 pg/ml which was a 20 fold increase over the amount of IFN-β 
produced by BMDCs after infection with Mtb H37Rv (Fig 11b). In order to 
demonstrate that this IFN-β secretion is important for AIM2-inflammasome activation, 
we infected BMDCs from WT and Aim2-/- mice with F. tularensis LVS and Msme in 
the absence or presence of neutralizing IFN-β antibodies and measured the IL-1β 
secretion after 24h (Fig 11c). The addition of neutralizing IFN-β antibodies 
significantly reduced the IL-1β secretion after infection with either F. tularensis LVS 
or Msme (Fig 11c). Consistently, the production of IL-1β was reduced by similar levels 
when BMDCs of WT or Ifnar1-/- mice were infected (Fig 11d). The neutralization of 
IFN-β had no effect on the IL-1β production after F. tularensis LVS or Msme infection 
of Aim2-/- BMDCs. These results suggest that IFN-β plays a similar role in the induction 
of AIM2 inflammasome activation by non-virulent mycobacterial species as it does 





2.4.3 Mtb Inhibits AIM2 Dependent IL-1β Production 
We addressed the hypothesis that Mtb can actively inhibit AIM2 inflammasome 
activation by performing mixed infection experiments. BMDCs from Nlrp3-/- mice 
were infected with Mtb or the esxA deletion Mtb mutant (ΔesxA) and either 4 or 8 hours 
post infection (hpi) the supernatants were harvested for analysis of IL-1β secretion (Fig 
12a and b). In Msme-infected BMDCs we detected about 100 pg/ml after 4hpi and 3000 
pg/ml after 8hpi. Interestingly, when Mtb infected BMDCs were challenged with 
Msme, we observed a 2-3 fold reduction in the amount of secreted IL-1β when 
compared to BMDCs infected only with Msme. The Mtb mediated inhibition was 
dependent on functional ESX-1 secretion system since infection with the ΔesxA mutant 
did not inhibit IL-1β secretion after challenge with Msme (Fig 12a and b).  
We also found that the rate of infection of Msme was not affected by the prior 
infection with Mtb as analyzed via flow cytometry using GFP-labeled Msme (Fig 13a). 
A similar inhibition by Mtb was also observed for IL-18 induced by Msme infections 
(Fig 13b). There were no differences in necrosis induction at 8hpi (Fig. 12b). To 
confirm the specific inhibition of the AIM2 inflammasome, we transfected the Mtb or 
ΔesxA infected Nlrp3-/- BMDCs with 0.5 µg/ml of poly (dA:dT) in the absence (Fig. 
12c) or presence (Fig. 12d) of LPS pre-treatment. Consistent with the previous finding, 
analysis of IL-1β showed that Mtb does inhibit the activation of the AIM2 






Figure 12:  Mtb inhibits AIM2 dependent IL-1β production. Nlrp3-/- BMDCs were 
first infected with Mtb or the Mtb ΔesxA mutant and then with Msme. Secreted IL-1β 
(blue bars) was measured by ELISA at (a) 4hpi (b) 8hpi, ***0.0001< p < 0.001 Msme. 
Necrotic cell death (red bars) was assayed is represented as fold change over uninfected 
(UI). Nlrp3-/- BMDCs in the (c) absence or (d) presence of LPS pre-treatment were first 
infected with Mtb or the Mtb ΔesxA mutant and then transfected with poly (dA:dT) for 
2 hours. Both secretion of IL-1β and necrosis were measured as before, ***0.0001< p 
< 0.001 LPS+DNA. Data is shown as the mean and standard deviation of triplicate 






Figure 13: Rate of infection of Msme-GFP and inhibition of IL-18 secretion by 
Mtb.  (a) Nlrp3-/- BMDCs left uninfected (UI), infected with either Mtb or Mtb ΔesxA 
first and then infected with Msme-GFP or with just Msme-GFP for 2 hours. Cells were 
harvested and analyzed by flow cytometry for GFP positive cells, ***0.0001< p < 
0.001 Msme GFP. (b) Supernatants from experiments described in Fig.3B were 
analyzed for IL-18 using a mouse IL-18 ELISA kit (MBL International), ***0.0001< 
p < 0.001 Msme. Data is shown as the mean and standard deviation of triplicate 













Since Mtb is able to actively inhibit the AIM2 inflammasome, we wanted to see 
if it exerted similar inhibitory effects on some of the other inflammasomes. Co-
infection experiments with Pseudomonas aerigunosa (activates the NLRC4 
inflammasome) demonstrated that Mtb was not able to inhibit NLRC4 inflammasome 
activation (Fig 14a and b). The mRNA and protein expression of pro-IL-1β was 
unaffected as were the proteins levels of both pro-caspase-1 and cleaved caspase-1. 
Tubulin is the loading control in cell lysates (Fig 14b).   
 
2.4.4 Mechanism of AIM2 Inflammasome Inhibition 
 
Finally, to further support our hypothesis that Mtb mediates inhibition of AIM2 
inflammasome activation, we investigated the mechanism of this inhibition. The 
immunoblots of cell lysates from infected BMDCs at 6 hpi showed that there is no 
difference in AIM2 protein expression (Fig 15a). Also, the protein expression of pro-
IL-1β and pro-caspase-1 was not affected by Mtb. However, immunoblots of the 
corresponding supernatants showed that there is decreased secretion of the p10 
fragment of caspase-1 and the mature IL-1β (p17) fragment in Mtb infected cells 
challenged with Msme when compared to Msme or MtbΔesxA/Msme infected cells even 
though similar amounts of protein was loaded for each condition (Fig 15a). 
Interestingly, Mtb infection reduced the amount of Msme-induced IFN-β secretion in 
an ESX-1-dependent manner (Fig 15b). Even the addition of high amounts of 
exogenous IFN-β (400 ng/ml) could only partially overcome the Mtb-mediated 
inhibition of Msme-induced IL-1β secretion (Fig 15c). These results demonstrate that 
Mtb is able to limit IFN-β production in infected host cells, which may explain some 








Figure 14: Mtb does not inhibit NLRC4 inflammasome activation. Nlrp3-/-BMDCs 
left uninfected (UI), infected with P. aeruginosa ΔexoU only (Pa) or first infected with 
Mtb (Mtb) or MtbΔesxA (ΔMtb) and then P.aeruginosa (a) IL-1β secretion measured 
by ELISA in supernatants at 3hpi, ***0.0001< p < 0.001 Pa (b) Western blot of 
supernatants (SN) for cleavage fragments of caspase-1 and IL-1β and cell lysates (CL) 
detecting pro-caspase-1, pro-IL-1β and tubulin. Experiments shown are representative 




To investigate if Mtb may also inhibit IFN-β signaling, we used IFN-β-/- 
BMDCs infected with Mtb and MtbΔesxA followed by treatment with IFN-β. The 
transcription of IFN-β–inducible genes Mx1 and PKR was analyzed by RT-PCR (Fig 
15d + e). In both cases Mtb infection reduced the IFN-β mediated increase in 
transcription but this inhibition was not dependent upon ESX-1, since the MtbΔesxA 















Figure 15: Mechanism of AIM2 inflammasome inhibition. Nlrp3-/- BMDCs were 
infected first with Mtb or the Mtb ΔesxA mutant and then with Msme. In (a) Western 
blots of supernatants (SN) showing active cleavage fragments of caspase-1 (p10) and 
IL-1β (p17) and cell lysates (CL) detecting pro-caspase-1 (p45), pro-IL-1β (p35), 
tubulin (p55) and AIM2 (p38) protein levels. (b) Secreted IFN-β was measured from 
supernatants collected 8hpi by ELISA, ***0.0001< p < 0.001 Msme. (c) Secreted IL-
1β from supernatants of untreated Nlrp3-/- BMDCs or those treated with IFN-β 
(400ng/ml) and then infected as indicated was measured 8hpi by ELISA, ***0.0001< 
p < 0.001 Mtb+Msme. (d+e) IFN-β-/- mice were infected with indicated bacteria and 
treated or not with IFN-β (700pg/ml) and the mRNA levels of Mx1 and PKR were 






The inhibition of IL-1β production by Mtb has been reported before [138] but 
the inhibition of IFN-β signaling by Mtb has not been shown previously to our 
knowledge. The precise molecular mechanism of the Mtb-mediated AIM2 
inflammasome inhibition remains to be elucidated. It seems unlikely that limiting IFN-
β production is the only pathway for Mtb to suppress AIM2 inflammasome activation 
since external addition of IFN-β did not induce IL-1β secretion in Mtb infected Nlrp3-
/- BMDCs (Fig 15c) and only partially restored the Mtb-mediated inhibition of Msme 
induced IL-1β. Hence, Mtb may secrete another effector that could inhibit signaling of 
the IFN-α/β receptor and/or directly modify AIM2 inflammasome activation. Indeed 
we provide evidence that Mtb inhibits IFN-β signaling. A detailed analysis of the large 
number of IFN-β regulated genes may reveal a subset whose expression can only be 
inhibited by Mtb with a functional ESX-1 system. This subset of genes would be the 
most likely to contain candidates for mediating the AIM2-inflammasome inhibition. 
Overall, the co-secretion into the host cell cytosol of Mtb eDNA and a putative AIM2-
inhibitor and/or IFN-β signaling inhibitor via the ESX-1 system may allow Mtb to take 
advantage of the type I IFN-mediated inhibition of the NLRP3-inflammasome without 
the Mtb eDNA inducing activation of the AIM2-inflammasome. The recent finding that 
Aim2-/- mice are very susceptible to Mtb infections supports the potential role of AIM2 
inflammasome inhibition for optimal virulence of Mtb [195]. Our discovery of a novel 
immune evasion mechanism engaged by Mtb opens the door for investigations into the 
identification of the Mtb genes involved in this inhibition and subsequent analysis of 
their importance for virulence of Mtb.  
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CHAPTER 3: AN ESAT-6 REGION DUPLICATED FROM ESX-5 




The ESX-5 secretion system of Mycobacterium tuberculosis (Mtb) is important 
for bacterial virulence and the secretion of the large PE/PPE protein family that 
constitutes 10% of the Mtb genome. A four-gene region of ESX-5 is duplicated three 
times in the Mtb genome but the function of these duplicates is unknown. Here we 
investigate one of these duplicates, the esxI, esxJ, ppe15 and pe8 (ESX-5a) region. 
ESX-5a deletion mutants in the Mtb and M. marinum (Mm) background are both 
deficient in secretion of the PE/PPE family of proteins. Surprisingly, using unbiased 
proteomics approaches, we also identified another protein that is not a member this 
family, thus expanding the range of ESX-5 secretion substrates. In addition, we 
demonstrate that the ESX-5a is important for virulence of M. marinum in the zebrafish 
model. In conclusion, the ESX-5a region is non-redundant with its ESX-5 paralog and 
is necessary for secretion of a specific subset of proteins that are important for bacterial 
virulence. Our findings point to an important role of the three ESX-5 duplicate regions 
in the selection of substrates for secretion via ESX-5 and hence they provide the basis 





3.2.1 Mycobacterial Type VII Secretion System 
Mtb is an extremely successful pathogen that employs various strategies to 
evade immune responses and persist within the host [20, 211]. Integral to this 
manipulation of the host by Mtb is the secretion of virulence factors by various 
secretion systems [135]. There are five different T7SS in Mtb (ESX-1 to ESX-5) [3, 
109]. The different ESX systems were most likely generated via duplications of the 
ancestral system ESX-4 in the chronological order of ESX-1, ESX-3, ESX-2 and lastly 
ESX-5 [95]. All the ESX secretion systems have a set of common genes, which form 
the core components of their secretion machinery among which are genes encoding for 
two members of the ESAT-6 like family (Esx proteins) [109,  223]. 
The region of difference 1 (RD1) is a 9.5 kbp stretch comprising of 9 genes of 
ESX-1 that is deleted in all strains of the live tuberculosis vaccine M. bovis BCG [22]. 
The importance of ESX-1 for virulence was first demonstrated by expressing the entire 
RD1 locus in the BCG vaccine strain and restoring virulence in the mouse model of 
tuberculosis [180, 181]. ESX-1 is essential for full virulence of Mtb in mice [110, 133, 
213]. In M. marinum (Mm), it is required for the growth of bacteria within 
macrophages, cell-to-cell spread and virulence in the zebrafish [92]. ESX-1 is required 
for the co-secretion of two ESAT-6 family proteins EsxA and EsxB [213]. The other 
known substrates are Rv3881c [238] and Rv3864 [40]. 
3.2.2 ESX-5 Secretion System 
The ESX-5 system is the most recently evolved of all the T7SSs and is only 
found in slow growing mycobacterial species [96]. It is important for the secretion of 
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the majority of the PE and PPE family of proteins [5, 6]. The PE/PPE families are 
unique to mycobacteria and are found mostly in pathogenic and slow growing 
mycobacteria where they expanded over time to now occupy approximately 10% of the 
Mtb genome. The PE proteins have a subfamily of proteins called PE_PGRS which 
stands for polymorphic GC-rich sequences. A number of these proteins are either 
surface exposed on the bacterium or secreted into the host milieu [48, 96]. ESX-5 
mediates the suppression of secretion of host cell pro-inflammatory cytokines TNF, IL-
6 and IL-12 after infection of macrophages with Mm [4]. After the bacteria escape from 
the phagosome into the host cell cytosol ESX-5 is required for the induction of caspase-
independent cell death in macrophages, which allows the bacteria to exit the host cell 
and infect new cells [2]. Hence it is not surprising that Mtb ESX-5 deficient mutants 
are attenuated in SCID mice [29] and Mtb lacking the ESX-5 PE-PPE proteins are 
strongly attenuated in immunocompetent mice [197]. 
3.2.3 ESX-5 Accessory Systems 
Besides their isolated location in the Mtb genome one pe and a ppe genes are also found 
flanking genes encoding for the ESAT-6-like proteins in each ESX loci except for the 
ESX-4 system [96, 109]. This shows that they most likely were first associated with 
the ESX-1 system and then co-duplicated thereof until they further expanded 
independently of ESX secretion systems [96].  
The two ESAT-6-like proteins and their flanking PE/PPE proteins from the 
ESX-5 system underwent three more duplication events (Fig 16) [96]. One of those 
loci is found in the Mtb genome starting at Rv1037c to Rv1040 (ESX-5a) containing 




Figure 16: Duplicated esat6/pe/ppe regions from the ESX-5 secretion system 
[adapted from 96] 




extracellular medium [142]. Interestingly, an EsxJ derived peptide constitutes a CD8 
T-cell epitope found in human individuals with latent or active tuberculosis [102]. 
The biological function of any of the three ESX-5 duplication regions has not been 
investigated to date. 
In the present study, we have characterized the role of ESX-5a in protein 
secretion, inflammasome activation, host cell cytokine secretion, host cell death 
induction and virulence during in vivo infections. Mm is a fish pathogen that is 
genetically very similar to Mtb. This mycobacterial species has been used as a model 
organism to study protein secretion via the T7SS and host-pathogen interactions using 
the zebrafish larvae [3, 4, 5]. Mtb ESX-5a deletion mutants did not secrete any alanine-
L-dehydrogenase (ALD) and showed partial reduction in secretion of PE/PPE family 
of proteins, which are ESX-5 substrates. The ΔESX-5a mutant does not activate the 
host cell inflammasome as much as wild-type Mtb and also shows reduced induction 
of the secretion of some pro-inflammatory cytokines. Nevertheless, the mutant shows 
no difference in apoptotic and necrotic cell death induction. Finally, the Mm ΔESX-5a 




3.3 Materials and Methods 
Mice  
C57Bl/6 wild-type mice were obtained from The Jackson Laboratories. Mice were 
maintained under pathogen-free conditions and used between 6 to 12 weeks of age. All 
studies were approved by the Institutional Care and Use Committee of The University 
of Maryland at College Park and were conducted in accordance with the IACUC 
guidelines and the National Institutes of Health Guide for the Care and Use of 
Laboratory Animals.  
 
Cell culture  
Bone marrow cells were obtained from the femurs and tibia of mice. Cells were then 
cultured in 100 Mm dishes for 7- 9 days in DMEM supplemented with Penicillin (100 
U/ml), Streptomycin (100 μg/ml), 2-mercaptoethanol (50 μM) (all from Invitrogen), 
10% heat-inactivated FCS (Hyclone), and either 200U/ml GM-CSF (Peprotech) to 
generate bone marrow-derived dendritic cells (BMDCs) or 20% L929 cell supernatant 
(LCCM) to generate bone marrow derived macrophages (BMDMs). The generation of 
BMDCs was performed as described [1]. Human myelomonocytic cell line THP-1 
(ATCC TIB-202) was cultured and differentiated using phorbol myristate acetate 







M. marinum (Mm) strain M, obtained from Dr.Gao (University of Maryland, College 
Park) was cultured and maintained as mentioned previously [93]. M. smegmatis (Msme) 
mc2155 and M. tuberculosis (Mtb) H37Rv (ATCC 25618) were obtained from Dr. W.R. 
Jacobs Jr. (AECOM).   
 
Generation of deletion mutants in Mm and Mtb  
Regions flanking the Mm genes esxP and esxN_2 (homologs of Mtb esxI and esxJ) was 
amplified by PCR and inserted on either sides of kanamycin resistant (Kanr) cassette 
contained in a pBluescript plasmid. The left fragment was generated using primers 
LLFP_esx (GATGGTACCTCTAGACCCATCGCCGCTGGCATTGG) and 
LLRP_esx (GCAGTCGACGATTCCTGTCTCCTTATGTTGAAGTCCGC) and the 
right fragment was generated using RLFP_esx 
(GCCGACTAGTTACAAGAGCAGGACAACAGTGGC) and RLRP_esx 
(GAATGAGCTCTCTAGAGGTAATACCGACCACCCACAC). This entire 
sequence was cut out from the plasmid and ligated into pLYG304.zeo. This knockout 
plasmid was electroporated into WT Mm and the resulting double crossover mutants 
Δesx- I/J were selected as described earlier [93]. The Mtb mutant ΔESX-5a was 
generated recombineering approach described in [14]. About 400-600bp flanking 
sequences on either side of the gene region Rv1037c-Rv1040c were amplified using 
PCR. The left fragment primers were Rvesx_LLFP 
(GCAACTCGAGCCGCCGTCAGGTGATCGAATCAG) and Rvesx_LLRP 
(GGAGAAGCTTGCTGGCTTAAGGCCCGCGCC) and the right fragment primers 
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were Rvesx_RLFP (GGCATCTAGAGCTGCTGTCTCCTTGTCTCGAAGTCG) and 
Rvesx_RL RP (GTGAGGTACCATCCCCACCGCGATATTCCTAGC). These were 
then ligated on either sides of a hygromycin resistance gene on the pMSG360 plasmid. 
This recombinant plasmid was then linearized and electroporated into a specialized 
strain of E.coli (EL350/phAE87). A recombination event between the phasmid phAE87 
and the linearized plasmid created a new phasmid containing the hygromycin marker 
and the flanking sequences. This phasmid DNA was extracted and transformed in Msm 
to generate recombinant phages that was then used for Mtb transduction. The 
hygromycin resistant Mtb colonies were picked and screened by southern blotting to 
confirm the knockout. EL350/phAE87 and pMSG360 were kind gifts from Dr. Michael 
S. Glickman, Memorial Sloan-Kettering Cancer Centre. 
 
Southern Blot 
Knockout confirmation in the mutants was done using Southern blot. The DNA probes 
for both Mm (FP- GGCAAACGCTCTCGATACC and RP- GCCGAATCGCGGAT 
AGATTAC) and Mtb (FP- CCGGACCGAACGGGATGAAC and RP-GTGCGTCT 
GGCGGCAGAAAC) mutants were biotinylated using BrightStar® Psoralen-Biotin 
Nonisotopic Labeling Kit (Ambion #AM1480) as per the manufacturer’s instructions. 
The genomic DNA digested using the restriction enzymes (Fermentas) PstI (Δesx- I/J) 
and BamHI (ΔESX-5a) and run on an agarose gel. The DNA from the gel was 
transferred to a nylon membrane and exposed to the biotinylated hybrization probe. 




Complementation of mutants  
The complementation of the Mm mutant Δesx-I/J was done by amplifying the gene 
fragment containing both the genes and ligating it in the plasmid, pLYG206.zeo [93]. 
This recombinant plasmid was electroporated into Δesx-I/J to generate the complement. 
Similarly, the fragment containing esxI and esxJ genes was amplified by PCR using the 
primers FP (GCACGAATTCAGCG GCCGGCAGGTTTCAC) and RP 
(GACCATCGATACGGCGCGGGCCTTAAGC) and ligated into pMV261. This 
recombinant plasmid was electroporated into ΔESX-5a to obtain a complement. 
 
Cell Culture and Infection 
Cultured medium containing differentiated BMDCs in suspension was collected and 
centrifuged. Cell pellets were then re-suspended in infection media containing only 
GM-CSF and seeded in 24 well plates. Bacteria were grown to an OD600 ranging from 
0.5 to 0.8 and centrifuged. The pellet was re-suspended in PBS (Cellgro) supplemented 
with 0.05% Tween-80 and centrifuged at 80g to remove clumps.   Infections were 
carried out at a multiplicity of infection (MOI) of 10:1 for 4h in infection media 
containing 10% non-heat inactivated FCS.  The extracellular bacteria were then 
removed by washing twice with PBS and the cells were incubated in chase media 
containing GM-CSF and 100μg/ml of gentamicin (Invitrogen) for 24h. In case of 
BMDMs the cells were seeded at least 16h before infection in complete media 
containing 20% LCCM. The cells were then washed and infection media was added to 
it (without LCCM) and infected 3h post LCCM starvation in conditions similar to 
BMDCs with the exception of GM-CSF addition.  THP-1 cells were seeded in 24 well 
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plates with PMA for 18-22h and then washed twice with PBS to remove the PMA. 
They were then re-suspended with infection media containing 5% of pooled human 
serum (Sigma) and infected with bacteria at an MOI of 3:1 for 4hrs. The extracellular 
bacteria were washed off and cells were incubated with chase media for 3 days. 
 
Cell death assays   
The adenylate kinase (AK) release assay, Toxilight®BioAssay (Lonza, Cat # LT07-
217) was used to quantify necrotic cell death. The assay was performed according to 
the manufacturer’s instructions using cell free supernatants harvested 1or 3 days post 
infection. The TUNEL assay was performed to reveal apoptosis-induced DNA 
fragmentation in THP-1 cells using the In Situ Cell Death Detection Kit, Fluorescein 
(Roche Applied Science #11-684-795-910). The assay was carried out as described by 
the manufacturer and the percentage of stained cells was analyzed using flow 
cytometry. For the detection of apoptosis in BMDM and BMDCs, hypodiploid stain 
was used. Cells were collected after infection, pelleted and re-suspended in propidium 
iodine (PI)/RNase buffer (BD Pharmingen #550825) for 20min and the percentage of 
hypodiploid positive cells was determined by flow cytometry. 
 
Cytokine Measurement 
ELISA was used to measure secreted IL-1β and pro-IL-1β in cells supernatant collected 
from infected cells at the indicated time points using BD OptEIATM Set Mouse IL-1β 
kit (BD Biosciences cat# 559603), BD OptEIATM Set Human IL-1β kit (#557953) and 
Mouse IL-1 pro-form ELISA (ebioscience # 88-8014) respectively. The analysis of 
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multiple cytokines in the BDMC supernatants was performed using the magnetic 10-
plex mouse cytokine panel (Life Technologies Cat# LMC0001M) and analyzed with 
the MAGPIX® system (Life Technologies). 
 
Preparation of culture filtrates (CF) and cell lysates (CL) 
Mm CF and CL preparation was done as previously described [238]. Mtb were cultures 
grown in 7H9 media to log phase, washed and then transferred to Sautons’ media (with 
0.05% Tween 80) at a starting OD of 0.05. These cultures were grown at 37°C in shaker 
(~100rpm) for 4 days (~OD = 0.8) and passaged again in 50ml of fresh Sautons’ media 
(with 0.005% Tween 80) to an initial OD of 0.05. The bacteria were allowed to grow 
for another 4 days and spun down to separate the pellet and supernatant. The CF was 
filtered and then concentrated using Amicon Ultra centrifugal filter units 
(Millipore#UFC900308). The CL was generated by re-suspending the bacterial pellet 
in 20Mm Tris-HCL (pH 7.6) and breaking up the cells using bead beating as described 
[238]. BMDC lysates preparation was performed as described earlier [1]. To detect 
cleavage fragments of caspase-1 and IL-1β, supernatants of infected cells were 
collected at indicated time points and subjected to methanol/chloroform extraction. The 




10µg of BMDC lysates were loaded onto an Any KD TGX SDS-PAGE gel (Bio-Rad 
#567-1123) and transferred to PVDF membranes. The blots were blocked using 5% 
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dry milk for 1 hour and then incubated overnight with the primary antibody. This was 
followed by incubation with HRP-conjugated secondary antibody for 1 hour. The 
membrane was then developed using the chemiluminescent pico substrate (Pierce 
#34078) and exposed on films (GeneMate #F-9023). The primary antibodies used 
were: anti-IL-1β (R&D systems #AF401NA) at 0.15µg/ml in 0.1% BSA, anti-caspase-
1 (Santa Cruz #sc-514) at 1:300 and anti-Tubulin (Cell Signaling #9774) at 1:1000. 
The above 2 antibodies were diluted in 5% dry milk with TBST. The secondary 
antibodies used were: Donkey anti-goat (Jackson #705-035-003) at 1:25,000, goat anti-
rabbit (Jackson #111-035-003) at 1:50,000 and goat anti-mouse (Jackson#115-035-
174) at 1:50,000 dilutions respectively. 
The bacterial CF and CL western blotting was done as mentioned above. The 
primary antibodies used were: ALD (NR-13651), SodA (NR-13810) and GroEL2 (NR-
13813) - from BEI resources used at dilutions recommended by them. Rabbit 
polyclonal serum FAP [184] was used at 1:8000. The anti-PGRS and anti-PPE41 
antibodies were kindly provided by Dr. Wilbert Bitter, VU University Medical Centre, 
Amsterdam and used at a 1:1000 and 1:20,000 respectively [6]. 
 
2D gel electrophoresis 
100µg of CF proteins were precipitated using the Readyprep 2-D clean-up Kit (Bio-
Rad #163-2130) and dissolved in 200µl of rehydration buffer. This solution was loaded 
onto an IEF tray and the first dimension was run on an 11cm IPG strip, pH 4-7 when 
placed in an IEF cell (Bio-Rad). The running conditions were: rehydration for 12 h, 
250 V for 20 min with linear ramp, 8000 V for 2.5h with linear ramp, and 8000 V with 
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rapid ramp at 20°C. Following this, the IPG strip was placed onto a 4-20% gel and the 
second dimension was run at 150V for 1hr. The gel was removed, washed and stained 
with Bio- safe coomassie for 90 min and de-stained overnight in DI water. A GS-800 
densitometer (Bio-Rad) was used to image the 2D gel. 
 
Mass spectrometry analysis 
Coomassie stained gel spots were analyzed according to the method of Shevchenko et. 
al. with minor modifications [203]. Briefly, gel spots were excised with a transfer 
pipette and destained via three consecutive 30 min incubations at room temperature in 
50/50 (v/v) 100Mm NH4HCO3/acetonitrile.  After the stain was removed, the excised 
gel pieces were dehydrated in 100% acetonitrile and subsequently rehydrated on ice in 
100Mm NH4HCO3 containing trypsin (Promega) at 20 ng/µL. The gel bands were 
allowed to fully rehydrate for 2 hours on ice, and then buffer was added to keep the gel 
pieces hydrated over the course of the digestion. Proteins were digested at 37º C 
overnight.  The resulting peptides were extracted by adding an equal volume of 5% 
formic acid in acetonitrile (v/v) and incubating for 30 minutes on a shaker. The peptides 
were removed and lyophilized to near dryness. 
Peptides were analyzed using an LTQ-Orbitrap XL (ThermoFisher) mass 
spectrometer coupled to a Prominence nano liquid chromatograph (nLC) (Shimadzu).  
As peptides eluted from the nLC precursor mass analysis was performed at high 
resolution while simultaneously fragmenting the 5 most abundant multiply charged 
precursors using collision-induced dissociation. The resulting spectra were searched 
against a mycobacterial database using the MASCOT search engine (Matrix 
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ScienceLondon, U.K.). Precursor masses were searched with a mass tolerance of 10 
ppm while product ion masses were searched within 0.8 Da.  Peptides were considered 
significant if identified with E-values less than 0.5. 
 
Real time PCR 
BMDCs were harvested 0 and 8h post-infection using TRIzol (invitrogen). Total RNA 
was extracted from these fractions using chloroform and precipitated with iso-propyl 
alcohol. The residual DNA was digested using Ambion® TURBO™ DNase as per the 
manufacturer’s instructions. Real time PCR was done using SYBR green PCR master 
mix (Roche) with GAPDH as the house-keeping gene. The samples were run on the 
Bio-Rad CFX96 Touch™ Real-Time PCR Detection System and the data was analyzed 
using the CFX software (version 3.0). The primers used were: IL-1β: 5’- 
AGCCTCGTGCTGTCGGACCC-3’/ 5’- TGAGGCCCAAGGCCACAGGT- 3’ AND 
GapDH: 5’- ATGGGATTTCCATTGATGACA- 3’/ 5’- 
CCACCCATGGCAAATTCC-3’ 
 
Survival studies using zebrafish 
The zebrafish were obtained from Dr. Du, University of Maryland, Baltimore County. 
All studies were approved by the Institutional Care and Use CoMmittee of The 
University of Maryland at College Park and were conducted in accordance with the 
IACUC guidelines and the National Institutes of Health Guide for the Care and Use of 
Laboratory Animals.  Prior to infection, the fish were exposed to 0.02% tricaine (ethyl 
3-aminobenzoate methanesulphonate) (Sigma-Aldrich #E10521) for 2-3 min and then 
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injected intraperitonially with 5–10 µl of Mm suspension in PBS containing 1x104 
bacilli. The control fish were injected with PBS only. For survival studies, eight fish 
were infected with each Mm strain. 
 
Statistical analysis   
Statistical analysis was performed on at least three independent experiments using 
GraphPad Prism 5.0 software and One-way ANOVA with Tukey’s post-test unless 
otherwise noted in the figure legends. Shown are representative results of triplicate 
values with standard deviation. The range of p-values is indicated as follows: * p=0.01< 




3.4 Results and discussion 
3.4.1 Generation of Mm and Mtb Deletion Mutants  
The Mm mutant was generated by deleting both esxP and esxN_1 (homologs of 
Mtb esxI and esxJ respectively) genes from the ESX-5a loci and is referred to as Δesx-
I/J. The Mtb mutant (ΔESX-5a) lacks the entire ESX5a region which includes the four 
genes: esxI, esxJ, ppe15 and pe8 (Fig 17). The gene deletions in both the mutants were 
confirmed using southern blotting (Fig 17). 
 
3.4.2 Identification of a Novel Secreted Substrate of ESX-5a 
 
The secretome of Mm (Fig 18a top panel) and the ESX-5a mutant - Δesx-I/J 
(Fig 18a bottom panel) was analyzed by subjecting their short-term culture filtrates 
(CF) to 2D gel electrophoresis (pH 4-7 and 6-70KDa). Based on a visual inspection, 
one major spot (labeled as 1) was found to be to be missing from the 2D gel of the 
mutant CF. In all our 2D gel electrophoresis repeats with multiple Mm WT and Δesx-
I/J CF samples, we found only spot 1 to be consistently absent in the mutant secretome. 
All other differences in secretion patterns between the mutant and WT could not be 
reproduced. For example, in the representative 2D gel image shown in Fig 18a, some 
of the spots seen in the Δesx-I/J CF are missing from the WT sample. These differences 
can be attributed to minor differences in protein amounts loaded onto the gel or due to 
excessive de-staining of coomassie from one of the blots. Spot 1 was identified as 
alanine-L-dehydrogenase (ALD) by mass spectrometry analysis and this was further 





Figure 17: Southern blot confirmation of Mm and Mtb deletion mutants. Schematic 
diagrams (left) of the genome regions in Mm and Mtb that contain the ESX-5a region 
and the Southern blots (right) are shown to confirm the deletion of (a) the esxI and esxJ 
genes from Mm and of (b) the esxI, esxJ, ppe15 and pe8 genes from Mtb. (Work done 




Here, we have used Fibronectin attachment protein (FAP) as a loading control. 
FAP is known to be exported via the SecA1 system, making it a good control as its 
secretion is not affected by any mutations made to the components of the T7SS. FAP 
is detected by a polyclonal anti-serum and shows up on the western blot as two closely 
spaced bands at 45 kDa with the top band usually more prominent than the lower band. 
GroEL, a 65 kDa cytoplasmic protein, is used as a lysis indicator. The ALD protein 
amounts in CF and CL from one representative blot was quantified using the imageJ 
software. The data is represented as a densitometric ratio of ALD to FAP (loading 
control) and is also relative to WT Mm. The quantification clearly shows a defect in 
both secretion and also in the expression of ALD by the mutant. Thus, in addition to a 
secretion defect, ESX-5a deletion could result in two possibilities: it affects either 
expression or stability of ALD. To see if this phenotype was conserved in Mtb, short 
term CF and cell lysates (CL) were collected from both the Mtb and the ΔESX-5a 
mutant and run on a SDS-PAGE gel. When the blots were probed with anti-ALD, no 
protein could be detected in the CL itself (lanes 1 and 2 of Fig 19a).  
Earlier reports have shown that ALD is up regulated during various stress 
conditions [25, 193]. Thus Mtb cultures were exposed to reactive oxygen species (ROS) 
for 0, 1.5 or 3 h and the cell lysates were prepared. Upon probing the CL blots with 
anti-ALD we could see some expression at 3 h in Mtb lysate and to a lesser extent in 
the mutant (Fig 19a).  
To conclusively show that there is an ALD secretion defect in the mutant we 





Figure 18:  Secretion defects in the Mm ESX-5a mutant. (a) 2D gel electrophoresis 
was performed on secreted proteins from M. marinum (top) and the ESX-5a deficient  
MmΔesx i/j mutant (bottom). The encircled protein spot was consistently absent in the 
mutant proteome. It was collected from the Mm gel and identified as alanine-L-
dehydrogenase via mass spectroscopy analysis. The 2D gel image is one representative 
of 2 independent experiments. (b) M. marinum (WT) and the ESX-5a mutant (Δesx i/j) 
secreted proteins (CF) and bacterial cell lysates (CL) were probed for ALD. The bar 
graph shows the quantification of ALD in CF and CL normalized to FAP and relative 
to WT Mm. Detection of GroEL is used as a quality control for the CFs, while the FAP 
signal serves as a loading control. All quantification was done imageJ. Data shown is 







Figure 19: Secretion defects in the Mtb ΔESX-5a mutant. (a) Mtb (1) and 
MtbΔESX-5a mutant (2) cultures were exposed to superoxide for different times as 
indicated and the corresponding cell lysates (CL) were probed for ALD (top) and FAP 
(bottom) by western blotting. In this particular image an empty lane between the 1st and 
2nd lane has been cropped. (b) The secreted proteins (CF) and CL from Mtb and 
MtbΔESX-5a strains constitutively expressing ALD were blotted for ALD, FAP and 
GroEL. The bar graph shows the quantification of ALD in CF and CL normalized to 
FAP and relative to WT Mtb. All data shown is one representative experiment out of 




and the quantification shows that only WT Mtb secretes ALD even though both Mtb 
and ΔESX-5a now express comparable amounts of the protein (Fig 19b).This result 
also indicates that the ESX-5a deletion might not affect ALD expression. Instead, it 
points to the possibility that inability of the mutant to export the ALD somehow affects 
the stability of the protein itself. This confirms that ESX5a is necessary for secretion 
of ALD in Mtb and Mm. 
3.4.3 ESX-5a Contributes to the Secretion of ESX-5 Substrates  
Since the ESX-5a region has been duplicated from the ESX-5 locus we wanted 
to see if the secretion of any ESX-5 substrates were affected in ΔESX-5a. When probed 
for the PGRS proteins, the Mm mutant was partially defective in the secretion of some 
of these proteins (Fig 20a). The antibody used here recognizes the PGRS motif and 
thus identifies multiple proteins from the family. The three PGRS protein bands labeled 
as 1, 2 and 3 were quantified and represented as a densitometric ratio of PGRS to the 
FAP relative to WT Mm. The ESX-5a deletion also affected the expression of two 
PGRS proteins (bands 1 and 3), which could possibly be a stability issue like with ALD. 
From the Mtb CF blots, we found that the mutant was partially defective in the secretion 
of PPE41, another known ESX-5 substrate and one PGRS protein (Fig 20b). In both 
these cases, quantification of the blots (done as before) shows that defect is solely in 
secretion of the proteins (Fig 20b). The above data also indicates that the accessory 
region could play a role in the secretion of ESX-5 substrates which points to some 




Figure 20: ESX-5a contributes to the secretion of ESX-5 substrates (a) Mm (WT) 
and the ESX-5a mutant (Δesx i/j) CF and CL were probed for PGRS family of proteins 
(PE sub-family) Three PGRS bands labeled as 1, 2, 3 were quantified and are shown 
below the blot (b) The Mtb and MtbΔESX-5a CF and CL were probed with antibodies 
against the ESX-5 substrates: PPE41 (PPE family member) and the PGRS-containing 
proteins with the quantification of CF and CL bands shown below. All quantification 
was done using the imageJ software and is normalized to the respective FAP protein 
bands (loading control) and is relative to WT. All data shown is one representative 




3.4.4 Secretion of ALD Requires the ESX-5 System  
The ESX-5a region lacks its own secretion machinery and since we found 
evidence of crosstalk with its parent system, we hypothesized that the ESX-5a 
substrates were also exported via the ESX-5 secretion system. Mm cultures: WT and 
the mutant with transposon insertions in the ATPase (eccA5) of the ESX-5 system were 
grown in sautons media. Their short-term CF and CL were collected, run on an SDS-
PAGE gel and subjected to western blotting. The blot was then probed with anti-ALD. 
The CL of eccA5::Tn showed ALD protein concentrations comparable to that of WT 
Mm and yet did not secrete any of it unlike the WT Mm (Fig 21) indicating the 
requirement of an intact ESX-5 system for its secretion. The western blot quantification 
was done ALD for both CF and CL and is represented as a ratio of ALD to FAP band 
intensity relative to WT Mtb. The absence of GroEL in the CF indicated that the 
supernatants were devoid of any cytosolic contamination. The blots were probed with 
anti-PGRS to show that both the transposon mutants were also defective in secretion 
of ESX-5 substrates. The eccA5::Tn was defective in the secretion of only some of the 
PGRS proteins. The increased secretion of some PGRS proteins seen in the CF of 
eccA5::Tn could be due to the difference in protein amounts loaded (FAP bands in 
eccA5::Tn CF are stronger than WT). These results thus confirm our hypothesis that 
the ESX-5a substrates are secreted through the parent ESX-5 system. 
 
3.4.5 Deletion of ESX-5a Does Not Affect Host Cell Death Induction 
 






Figure 21: ALD is secreted via the ESX-5 system. Cell lysates (CL) and cell 
supernatant filtrates (CF) were collected from Mm wild-type (WT) and transposon 
insertions mutant in the ESX-5 ATPase   (eccA5::Tn). The western blots were probed 
for ALD, GroEL, FAP and PGRS. Data shown is one representative experiment out of 




It is most likely that Mtb inhibits cell death induction during initial phase of replication 
but induces cell death later on in order to exit the host cell [20]. Esx-5 deficient Mtb 
and Mm induce less host cell death [2]. To assess apoptotic cell death in macrophages, 
THP-1 cells were infected with Mtb, ΔESX-5a and its complement (ΔESX-5aC) for 3 
days. The apoptosis rates were calculated as the percent of TUNEL positive cells using 
flow cytometry. Both Mtb and the mutant induced very similar rates of apoptotic death 
of about 20% while the complement induced rates slightly higher (Fig 22a). This small 
increase could be attributed to the fact that in the complement the ESX-5a region is 
constitutively expressed which may lead to higher protein levels when compared to 
Mtb. Death by necrosis was measured by the release of cytosolic adenylate kinase (AK) 
into the supernatant. The cells were collected for measuring apoptosis while the cell 
supernatants were collected to measure necrosis. Both the mutant and the complement 
showed no difference in necrotic cell death when compared to Mtb. All three bacterial 
strains induced about 3 fold higher levels of AK in the supernatant than uninfected cells 
(Fig 22a). Cells treated with 1% Triton X-100 were used as a positive control. In 
primary mouse bone marrow derived dendritic cells (BMDC) infected with the 
bacterial strains for 24h the hypodiploid positive population in Mtb and mutant was 
around 47% and this was slightly higher in the complement at about 60%. Similarly, 







Figure 22: ESX-5a deletion has no effect on host cell death induction. Apoptotic 
cell death (red bars along the left Y axis) induction was measured in THP-1 
macrophages by TUNEL assay at day 3 (a) and in BMDCs by hypodiploid staining at 
day 1 (b) while the release of adenylate kinase into the supernatant as a measure of 
necrosis (blue bars along the right Y axis) is shown as fold change over uninfected cells 
(UI) in (a) and (b). ***0.0001< p < 0.001, Mtb. Data are shown as the means ± standard 
deviation (SD) of triplicate measurements of one representative experiment out of 




3.4.6 Inflammasome Activation is Reduced in Bacteria Lacking a Functional ESX-
5a  
The activation of the inflammasome and the secretion of mature IL-1β by 
BMDMs and BMDCs after Mtb infection are dependent on a functional ESX-1 
secretion system [1,129, 212]. In Mm, both ESX-1 and ESX-5 secretion systems have 
been shown to be required for IL-1β secretion [2]. So we investigated the effect of 
ESX-5a deletion on IL-1β secretion in THP-1 cells, BMDMs and BMDCs. THP-1 cells 
were infected with Mtb, ΔESX-5a and ΔESX-5aC at an MOI 3 and the supernatants 
were assayed for IL-1β secretion by ELISA 3 days post infection. The mutant showed 
around 50% reduction in cytokine secretion when compared to both Mtb and 
complement (Fig 23a).  
BMDMs and BMDCs were infected at an MOI of 10 and the cell-free 
supernatants were analyzed for IL-1β secretion 24 h post infection. BMDCs infected 
with the mutant also showed a 50% reduction in secretion of IL-1β (Fig 23b) while in 
BMDMs it is completely abrogated (Fig 23c). All supernatants were tested for release 
of AK as a control for contamination with cytosolic contents due to necrosis and there 
was found to be minimal induction after infection with all three strains and no 
differences between the strains (blue bars in Fig 22b). Additionally, the BMDC 
supernatants showed slight reduction in the secretion of some other pro-inflammatory 
cytokines (Fig 24).  
Inflammasome activation is a two-signal process ultimately leading to the 
production of mature inflammatory cytokines like IL-18 and IL-1β. The first signal 




Figure 23: ESX-5a deletion in Mtb reduces the secretion of IL-1β by infected host 
cells. IL-1β ELISAs were performed on supernatants from cells infected with Mtb, 
ΔESX-5a or its complement (ΔESX-5aC) in (a) THP-1 cells at day 3 post infection or 
(b) mouse BMDC and (c) mouse BMDMs at 24h. ***0.0001< p < 0.001, Mtb. Data 
are shown as the means ± SD of triplicate measurements of one representative 





Figure 24: Multiplexed cytokine analysis of infected BMDCs. BMDCs were 
infected with Mtb, the ESX-5a mutant (ΔESX-5a) and complemented mutant strain 
(ΔESX-5aC) and after 24h the supernatants were analyzed for expression of the 
indicated cytokines using a multiplexed magnetic mouse cytokine panel. ***0.0001< 
p < 0.001, Mtb. Data are shown as the means ± SD of triplicate measurements of one 




The second is required for caspase-1 activation via the inflammasome. In order to 
identify at what point the ΔESX-5a mutant resulted in reduced activation the mRNA 
and cell lysates of infected BMDCs were collected to check for expression of pro-IL-
1β at both transcriptional and translational levels. We observed that there was no 
difference in expression of pro-IL-1β mRNA between mutant and Mtb after four hours 
of infection (Fig 25a). The protein levels of pro-IL-1 β were also found to be similar 
(Fig 25b). So next we analyzed caspase-1 activation by blotting for activated, cleaved 
caspase-1 (p10) in the supernatants of infected BMDCs. All infection conditions used 
the same number of cells and from these, the entire supernatant was collected. This was 
done to ensure that any variation in the amount of protein detected was not due to 
differences in concentration of loaded samples. The proteins were extracted from these 
supernatant samples were then probed for caspase-1. Signal for activated caspase-1 was 
clearly visible in supernatants of both Mtb and complement infected cells but reduced 
in the mutant infected cell supernatants (Fig 25b). The complement infected sample 
showed more of the cleaved caspase-1 fragment, possibly because the ESX-5a region 
in the complement is constitutively expressed. In conclusion, the absence of ESX-5a 
proteins reduces the generation of mature IL-1β via reduced activation of the 
inflammasome leading to the generation of less active caspase-1.  
 
3.4.7 ESX-5a Contributes to Virulence of Mm in Zebrafish 
Zebrafish is an in vivo model for Mm infections that has been extensively used 
to understand mycobacterial pathogenicity mechanisms that can be translated into the 




Figure 25: ESX-5a deletion in Mtb reduces the host cell inflammasome activation. 
(a) The mRNA levels of pro IL-1β were measured in BMDCs infected with Mtb, the 
ESX-5a mutant (ΔESX-5a) and complemented mutant strain (ΔESX-5aC) right after 
the 4h infection period using quantitative RT-PCR. ***0.0001< p < 0.001, Mtb (b) 
Western blots of supernatants (SN) collected at 6h post infection showing the active 
fragments of caspase-1 (10kDa) and IL-1β (17kDa), respectively. The corresponding 
cell lysates (CL) were probed for procaspase-1 (45kDa), pro-IL-1β (35kDa). Tubulin 
(55kDa) signal serves as the loading control. Data are shown as the means ± SD of 




To determine the effect of the ESX-5a region on virulence of mycobacteria as indicated 
by survival, the zebrafish were injected intraperitoneally (i.p) with PBS, Mm, ΔesxI/J 
and ΔesxI/J-C (complement) at a CFU of 104/fish and monitored for up to 80 days. 
There were 10 fish per experimental group and the PBS injected fish were kept as a 
control group to negate the possibility of death due to needle injuries. Most of the Mm 
and complement bacteria infected fish died within 3-5 weeks whereas a bulk of the 
ΔesxI/J mutant infected fish started dying only after 5 weeks (Fig 26). This shows that 








Figure 26: Virulence defect of the Mm ESX-5a mutant. Adult zebrafish were 
injected intraperitoneally (ip) with 104 bacteria per fish of M. marinum (WT Mm), the 
Mm ESX-5a deficient Δesx i/j mutant (Δesx i/j) and the complemented mutant strain 
(Δesx-i/jC) and monitored for survival. There were 10 fish per group (n=10) with saline 
(PBS) injected fish as a control group. **0.001< p < 0.01, WT Mm. Data are shown as 
the means ± SD of triplicate measurements of one representative experiment out of 
three. Statistical analysis was performed using log-rank test. (Work done by Shah S 





We demonstrate that the deletion of ESX-5a locus partially affects the secretion 
of some ESX-5 system substrates like PPE41 and PGRS proteins (Fig 20). Since the 
ESX-5a region does not include genes that code for the core secretory machinery, such 
as a channel protein, it must utilize another secretion system for protein export. Our 
finding that there is an overlap in secretion substrates between the ESX-5 and ESX-5a 
system points to the possibility of crosstalk between the ESX-5 secretion system and 
ESX-5a. This is supported by our finding that Mm transposon mutant of AAA ATPase 
(eccA5) is also deficient in the secretion of ALD (Fig 21) as is the Mm ESX-5a deletion 
mutant (∆esxi/j) (Fig 18a+18b). Hence, we propose a model in which the ESX-5 system 
encodes for the core secretion machinery whereas ESX-5a is important for chaperoning 
a subset of ESX-5 secreted proteins (Fig 27). This model suggest that all three ESX-5 
duplicated regions: Rv1195-Rv1198, Rv1037c-Rv1040c and Rv3619c-Rv3622c could 
potentially play a role in protein secretion in conjunction with the parent ESX-5 and 
that all these different loci contribute to the overall secretory functioning of the ESX-5 
system.  
Mtb has 168 members of the PE/PPE family of proteins in it genome, which accounts 
for about 10% of the total genome. The function of these proteins is not well 
understood. Their expression was hypothesized to provide antigenic variability in order 
to favor evasion of the host immune response. One problem with the study of individual 
members of a large protein family is the high chance of redundancy and thus loss-of-





Figure 27: Model of ESX-5 and replicate ESAT-6 regions function in protein 
secretion. The ESX-5 ESAT-6 region Esx protein pair (EsxM and EsxN) and its 
duplicate paralogs are indicated. The circles represent putative secretion substrates 
associated with each of these systems. We propose that they all feed into the core 
components of the ESX-5 system represented here by the putative channel protein 
EccD5 and the ATPase EccA5. The plasma membrane (PM) and the mycomembrane 




Our results led to the hypothesis that the ESAT-6 duplicate regions of ESX-5 
are important for selection of substrates to be secreted by ESX-5. Thus by deleting each 
of the three duplicated regions and determining the phenotype of the mutant and the 
secretion defect it should be possible to attribute a function a smaller subset of the 
PE/PPE protein family. For example, the ESX-5a mutant has no cell death phenotype, 
which is different from an ESX-5 mutant, and therefore we can conclude that the ESX-
5a substrates are not involved in cell death induction. This approach may help in 
characterizing the function of various PE/PPE proteins. 
The molecular mechanism of substrate selection for type VII secretion systems 
is a matter of great interest and intense research efforts. Recently, a short peptide motif 
(YxxxD/E) in the C-terminus of proteins was identified as a general signal for type VII 
secretion [55]. However, this signal does not determine ESX specificity since 
exchanging it on ESX-1 and ESX-5 substrates did not change their respective secretion 
pathway [55]. Another characteristic of ESX and PE/PPE secretion substrates is the 
formation of heterodimers, which are essential for successful secretion and which result 
in the generation of a characteristic four-helix bundle [109]. These characteristics have 
been used to develop an algorithm to predict novel T7SS substrates [55]. Interestingly, 
ALD does not have the structural features or an YxxxD/E motif, which would identify 
it as a T7SS substrate. Consequently, it is possible that another group of T7SS 
substrates exist which remains to be identified. This task maybe complicated by the 
fact that other T7SS may only be highly expressed in Mtb after infection of host cells, 
similar to ALD, which makes these T7SS impossible to identify using the standard ex 
vivo proteomics approaches.  
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Mtb infection activates the host cell inflammasome which results in the 
generation of mature secreted IL-1β. The active inflammasome consists of a variable 
sensing component (most often an NLR), the adaptor protein ASC and pro-caspase-1 
[199, 224]. In the case of Mtb infections of macrophages or dendritic cells only the 
NLRP3-inflammasome is activated [1, 33, 41, 70, 153, 154, 162, 236]. There are 
several agonists that induce activation of the NLRP3 inflammasome such as an increase 
in ROS, nigericin, ATP, bacterial toxins and particulate matter [114, 165, 219]. All of 
these agonist share that they induce K+ efflux, which is the common trigger for the 
NLRP3-inflammasome [165]. A central role was recently attributed to the 
mitochondria, since during mitochondrial dysfunction cardiolipin is relocated to the 
outer mitochondrial membrane where it can bind to and activate NLRP3 [114]. Here 
we demonstrate that the Mtb∆ESX-5a mutant does not induce NLRP3-inflammasome 
activation as efficiently as the wild-type bacteria. We show that this defect is not due 
to a lack of signaling to induce pro-IL-1β or pro-caspase-1 transcription or translation 
(Fig 25a+25b) but because of the disruption of activation of the inflammasome (Fig 
25b). In the absence of either the ESX-1 or ESX-5 systems there is a reduction of 
mature IL-1β secretion by the host cells into the supernatants [1, 2, 129, 213] . It is thus 
somewhat surprising that the deletion of the ESX-5a region also has such a strong effect 
on inflammasome activation. One interpretation of the results is that the reduced 
inflammasome activation observed with the ESX-5 mutant is actually due to a lack of 
secreted substrates dependent on the ESX-5a region and hence the deletion of ESX-5a 
has a similar effect to ESX-5 deletion. It seems unlikely that the inflammasome 
phenotype of the Mtb ESX-5a mutant is linked to cell death induction as it has been 
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reported for the Mm ESX-5 mutant [2] since cell death levels are not affected by the 
ESX-5a deletion in Mtb (Fig 22). This implies that the secreted ESX-5a substrates have 
no role to play in host cell death induction. 
The appearance of the ESX-5 system in the genomes of slow growing 
mycobacteria demarcates them from the fast growing mycobacterial species [96]. Most 
of its secreted substrates are from the PE/PPE protein family that is considerably 
expanded in the slow growing species [6, 29, 96]. Since all of the pathogenic 
mycobacterial species adapted towards infection of a host are also slow growing, this 
correlation suggests that the ESX-5 system is involved in virulence. Indeed, the Mtb 
ESX-5 deletion mutants were attenuated upon in vitro infection of macrophages and in 
vivo infections using the mouse model [29, 197]. Our study shows that Mm ESX-5a 
mutant is attenuated in the adult zebrafish when compared to both the wild-type Mm 
and the complement mutant strain (Fig 26). This result indicates that the substrates of 
this accessory ESX-5 secretion system are necessary for full virulence of mycobacteria. 
Another possibility for the attenuation seen in mutant infected fish could be due to the 
inability of the bacteria to replicate normally even though the mutant did not show any 
growth defects when cultured in vitro. In any case, the decreased in vivo fitness of the 
mutant could attribute to virulence attenuation. Consistently, the transcription of two 
genes of the ESX-5a region (esxI and esxJ) is highly up-regulated in bacteria isolated 
from human tuberculosis patients or from the lungs of infected mice [37]. Thus, it 
would be interesting to see if the Mtb ΔESX-5a is attenuated in mice as seen with the 
Mm mutant in zebrafish. Altogether, our findings point towards an important function 
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Mtb is a highly infectious organism and is one of the leading causes of death in 
third world countries. Mtb primarily resides within macrophages and inhibits host cell 
apoptosis to protect its replicative niche. Apoptosis is an important innate defense 
mechanism employed by the host immune cells to clear intracellular pathogens. A gain 
of function screen using avirulent M. smegmatis (Msme) and M.kansasii (Mkan) 
identified three unique genomic regions of Mtb with anti-apoptotic activity. Using 
different experimental approaches, gene products from one of the regions (M24) were 
systematically assessed for their ability to inhibit host cell apoptosis. One of the genes 
from the M24 region - Rv1048c was found to have an anti-apoptotic function. Rv1048c 
encodes a conserved hypothetical protein and is contained on a genomic island that is 





4.2.1 Cell Death Mechanisms for Host Defense 
Multiple modes of cell death are important host immune defense mechanisms 
in the event of a microbial infection, so much so that many pathogens are known to 
manipulate cell death pathways for gaining a survival advantage. There are various cell 
death modalities such as apoptosis, pyroptosis, necroptosis etc. that are important for 
controlling infections. Pyroptosis is an inflammatory mode of programmed cell death 
that is dependent on caspase-1 activation. This form of cell death was required for the 
clearance of intracellular bacteria such as S.typhimurium, L.pneumophilia and 
B.thailandensis [157]. Necroptosis, or programmed necrosis, is dependent on the 
activity of RIPK1 and RIPK3 for cell lysis and release of DAMPs (Danger Associated 
Molecular Patterns) such as HMGB1, IL-1α etc. along with its cytoplasmic contents 
[121]. Necroptosis is important for the control of Vaccinia Virus infection [45]. 
Apoptosis is an immunologically silent form of programmed cell death that is a primary 
innate defense mechanism against many viral and bacterial pathogens. It serves to play 
two important roles in controlling infections. One, it eliminates the pathogen along with 
its replicative niche without inducing an inflammatory response and two, the resulting 
apoptotic bodies with the pathogenic antigens are taken up DCs, processed and 
presented via MHC class I molecules to cytotoxic CD8 T-cells to ultimately mount an 






4.2.2 Effects of Apoptosis on Mycobacterial Survival 
Macrophage cell death by apoptosis is known to affect the viability of various 
mycobacterial species [66, 88, 164].  However, the death of invading pathogens cannot 
be completely attributed to the apoptosis of the primary infected cells. When the cells 
undergo apoptosis they are broken down into smaller vesicles that are then take up by 
other neighbouring phagocytes in a process known as “efferocytosis” (Fig 28) [149]. It 
has been shown that uninfected macrophages contribute to controlling bacterial growth 
in vitro [88]. Another group has shown that same phenomenon in vivo by using a novel 
LIVE/DEAD Mtb reporter strain. They demonstrated that most of the bacteria 
contained in efferocytic cells were dead and that apoptotic vesicle + Mtb- containing 
phagosomes in these cells can now seem to mature as they become acidic and also 
accumulate the lysosomal marker Lamp1 on their surface [149]. 
Using zebrafish infected with its natural pathogen, M. marinum (Mm), it was 
found that the initiation of apoptosis is important for the recruitment of neutrophils to 
the site of the granulomas. Here the neutrophils did not seem to phagocytize 
extracellular Mtb but acquired them through efferocytosis. After which, the ingested 
mycobacteria were killed by the generation of ROS via the NOX2 complex [240]. 
Induction of apoptosis is an innate immune response mounted by the host 
against foreign invasion. Subsequently, the apoptotic blebs containing bacterial 
antigens are taken up by dendritic cells which process them through the MHC class I 
molecules and present the peptides to naïve CD8 T-cells leading to the onset of adaptive 






Figure 28: Mtb killing by efferocytosis [adapted from 149]. 
The neighboring phagocytes engulf apoptotic bodies released from primary infected 
macrophages. These apoptotic bodies contain live bacteria. The phagosome of the secondary 
macrophages containing Mtb+apoptotic bodies can now undergo fusion with the lysosome 




The vaccination of mice with apoptotic vesicles containing Mtb, was enough to 
prime naïve T-cells against a virulent Mtb challenge [235]. Divangahi et al, show that 
inhibition of apoptosis by Mtb delays the onset of adaptive immunity by preventing 
cross-presentation via CD11c DCs through a series of elegant experiments. In the 
presence of LXA4, infected macrophages tend to die from necrosis. Therefore by 
knocking out this gene, the macrophages are found to have a higher propensity for 
undergoing apoptotic cell death upon mycobacterial infection. The alveolar 
macrophages from the LXA4 knockout mice were intratracheally transferred into WT 
mice which were then infected with virulent Mtb. These mice were found to have a 
higher percentage of CD8 T-cells specific for Tb10.4 antigens in the lungs and 
peripheral lymph nodes when compared to mice that received WT alveolar 
macrophages. The apoptosis dependent expansion of T-cell population specific to Mtb 
antigens requires the presence of CD11c+ DCs and an intact MHC class I system. [67]. 
 
4.2.3 Mechanisms of Mycobacterial Inhibition of Apoptosis 
Virulent Mtb has developed several ways to inhibit host cell apoptosis early on 
and later push the cell to undergo necrosis. This way the bacteria are released from the 
cells and can re-infect other cells leading to disease dissemination whereas avirulent 
mycobacteria induce host cell apoptosis upon infection [123].  
Virulent Mtb does still induce very low levels of programmed cell death due to 
proteins like EsxA [62] and 19kDa lipoproteins [46]. These bacterial effectors however 
are important for virulence and therefore to compensate, it is quite possible that Mtb 
employs other anti-apoptotic mechanisms to actively suppress apoptosis levels to the 
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minimum early on in the infection and later cause necrosis to promote bacterial escape 
to the extracellular milieu [179]. It has also been reported that virulent Mtb is able to 
inhibit apoptosis when infected in vitro at a low MOI (Multiplicity of Infection) but at 
higher MOIs, it induces cell death independent of caspases. This form of host cell death 
resembles necrosis at later stages and is most likely a mechanism to promote its 
extracellular dissemination [131].  
TNF is indispensable for apoptosis induction in host cells and virulent Mtb is 
known to increase secretion of soluble TNFR2 from host cells to neutralize the cytokine 
[87]. TNF can signal for either cell survival or apoptosis. ROS is a major determinant 
which pushes the signaling pathway towards JNK and p38 MAPK, thereby ensuring 
that the cell undergoes TNF dependent apoptosis [160]. Recently a slew of studies 
showed that virulent Mtb manipulates the eicosanoid biosynthetic pathways to push the 
cell away from apoptosis and induce necrosis instead. This involved inhibiting PGE2 
production and thereby increasing amounts of LXA4. As a result, the cells could no 
longer repair the damage done to the plasma membrane or complete the formation of 
the “apoptotic envelope” [Reviewed in 21].  
 
Bacterial Effectors in Apoptosis Inhibition  
Proof of mycobacterial inhibition of host cell apoptosis is validated by the 
identification of numerous pro-apoptotic deletion mutants. Some of the proteins 
identified as anti-apoptotic were SecA2 and PknE (protein kinase E). SecA2 encodes 
an accessory secretion system required for the export of virulence factors like SodA 
(Superoxide Dismutase A) which is involved in neutralizing superoxides generated by 
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the host cells. The secA2 deletion mutant induced high levels of host cell apoptosis. 
This phenotype could be complemented when SodA with an antigen85 signal peptide 
was added to allow its secretion through SecA1 system implying that the actual anti-
apoptotic effector is SodA [106]. The deletion mutant of PknE was more susceptible to 
nitric oxide exposure and also induced higher levels of host cell apoptosis as compared 
to WT Mtb [115]. The promoter of PknE is up-regulated during nitrosative stress and 
the protein is able to cause increased phosphorylation of a MAPK (ERK 1/2), which 
ultimately leads to host cell survival [175]. Another study identified Rv3654c and 
Rv3655c proteins as being anti-apoptotic. These two proteins belong to a “type IV pili” 
operon and are secreted into the macrophage cytosol where they interact with host 
proteins PSF and ALO17 respectively and affect the availability of caspase-8. As a 
result, Mtb is able to interfere with the extrinsic apoptotic pathway [56]. 
   Previously, a gain of function screen was done to systematically identify anti-
apoptotic genes in virulent Mtb. Around 40kbp fragments of the genome of the virulent 
Mtb Erdman strain were ligated into the episomal cosmid pYUB415. These clones were 
then transformed into avirulent mycobacterial species that are known to strongly induce 
apoptosis, such as Mkansasii (Mkan) and M. smegmatis (Msme) [125]. THP-1 cells 
were infected with the Mkan transformants and the cells were harvested 5 days post 
infection (dpi) for a TUNEL assay to gauge the levels of apoptosis. Both WT Mkan 
and Mkan with empty cosmid (CO) infected conditions were almost completely 
apoptotic while only about 10% of Mtb infected cells were dying. Mkan+ J21 and M24 
infected cells resembled the Mtb infected condition. Therefore, it was concluded that 





Figure 29:   Apoptosis induction by Mkan+J21 and Mkan+M24.   
THP-1 cells were infected with WT Mkan, Mkan transformed with empty cosmid (CO), J21 
and M24 and WT Mtb.  The cells were harvested 5dpi and the levels of apoptosis shown as 
percent TUNEL positive cells. Results are represented as an average of three independent 
experiments. Statistical significance is relative to WT Mkan and is indicated as * 0.01<p<0.05, 




have gained the function of apoptosis inhibition (Fig 29). A third anti-apoptotic, Mtb 
genomic region to be identified was called K20. The first anti-apoptotic gene to be 
identified using this screen was from the J21 cosmid, namely, nuoG. An Mtb mutant of 
NuoG, a protein of the Type I NADH dehydrogenase complex was found to induce 
higher levels of apoptosis in infected BMDMs as well as THP-1 macrophages [230]. 
The pro-apoptotic phenotype of ΔnuoG could be attributed to the induction of 
phagosomal ROS via NOX2 system that ultimately led to TNF production and 
apoptosis [160]. 
In the current study, the M24 cosmid consisting of 38 Mtb genes (Fig 30), was 
subjected to multiple loss of function genetic approaches to identify the gene(s) 
responsible for inhibiting apoptosis. The M24 region consists of many operons, such 
as the kdp operon (regulates potassium uptake), the Esx-5a region (involved in protein 
secretion and virulence), Rv1041c-Rv1055 (a genomic island mostly encoding for 
proteins of unknown function). From the M24 region, a novel anti-apoptotic gene 
called Rv1048c was identified. This gene encodes for a conserved hypothetical protein 
of an unknown function and is found on a genomic island that is exclusively present in 




Figure 30: Mtb genomic fragment in M24 cosmid 
Genes within known operons or in same functional groups are in similar colours. The red line 
indicates the genomic island (Rv1041c-Rv1055) that is unique to the Mtb complex and the 
gene found in a blue circle (Rv1048c) is the identified anti-apoptotic gene.
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4.3 Materials and Methods 
 
Bacterial strains 
Mtb CDC1551 WT strain was a kind gift from Dr. Gilla Kaplan. The CDC1551 
transposon insertions were obtained from the TARGET repository at BEI resources. M. 
smegmatis (Msme) mc2155 and M. tuberculosis (Mtb) H37Rv (ATCC 25618) were 
obtained from Dr. W.R. Jacobs Jr. (AECOM).  M. kansasii strain Hauduroy (ATCC 
12478) was purchased from American Type Culture Collection (ATCC). The Bacterial 
strains were cultured as mentioned before [230].  
 
Cell Culture and infection 
The cell system used was THP-1(ATCC TIB-202), a human myelomonocytic cell line. 
THP-1 cells were grown in RPMI (ATCC) medium with 10% heat inactivated fetal calf 
serum (Hyclone). The cells were seeded in 24 well plates at a density of 0.75 million 
cells/ml/well and differentiated with PMA from Sigma (phorbol 12-myristate 13-
acetate) at a 2000x dilution for 18-22 hours. They were then washed twice with PBS 
and left in 500ul of RPMI media with 5% human serum (Sigma) and infected at an 
MOI 3 for 4 hours.  After which, the chase medium containing RPMI+10% calf serum 
and 100µg/ml gentamicin (Invitrogen) and harvested 3-4 days post infection. 
 
TUNEL Assay 
The TUNEL assay was performed to reveal apoptosis-induced DNA fragmentation in 
THP-1 cells using the In Situ Cell Death Detection Kit, Fluorescein (Roche Applied 
Science #11-684-795-910). The assay was carried out as described by the manufacturer 
and the percentage of stained cells was analyzed using flow cytometry. 
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Mtb gene deletion mutant generation by Recombineering 
The Mtb mutant ΔESX-5a was generated using the recombineering approach described 
in [14]. About 400-600bp flanking sequences on either side of the gene region 
Rv1037c-Rv1040c were amplified using PCR. The left fragment primers were 
Rvesx_LLFP (GCAACTCGAGCCGCCGTCAGGTGATCGAATCAG) and 
Rvesx_LLRP (GGAGAAGCTTGCTGGCTTAAGGCCCGCGCC) and the right 
fragment primers were 
Rvesx_RLFP(GGCATCTAGAGCTGCTGTCTCCTTGTCTCGAAGTCG) and 
Rvesx_RL RP (GTGAGGTACCATCCCCACCGCGATATTCCTAGC). These were 
then ligated on either sides of a hygromycin resistance gene on the pMSG360 plasmid. 
This recombinant plasmid was then linearized and electroporated into a specialized 
strain of E.coli (EL350/phAE87). A recombination event between the phasmid phAE87 
and the linearized plasmid created a new phasmid containing the hygromycin marker 
and the flanking sequences. This phasmid DNA was extracted and transformed in 
Msme to generate recombinant phages that was then used for Mtb transduction. The 
hygromycin resistant Mtb colonies were picked and screened by southern blotting to 
confirm the knockout. EL350/phAE87 and pMSG360 were kind gifts from Dr. Michael 
S. Glickman, Memorial Sloan-Kettering Cancer Centre. 
 
“LoGoF” (Loss of Gain of Function) Screen 
The original gain of function cosmid labelled as M24 was subjected to transposon 
mutagenesis using HyperMu transposon (Epicentre Technology) according to the 
manufacturer’s instructions. Thus a library of M24 cosmids, deficient in the expression 
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of a single gene, was generated. The clones were screened and sequenced to identify 
the transposon insertion sites. These were then transformed into WT Mkan. Hence, 
these transformants carry a mutant gain-of function M24 cosmid where one of the genes 
in the cosmid is inactivated. Therefore they are called Loss of Gain of Function 
(“LoGoF”) mutants.  
 
Complementation of Rv1048c 
Rv1048c gene was amplified by PCR and the gene product was then cloned into an 
integrating plasmid, pDB60 [14]. This plasmid was transformed into Rv1048c::Tn 
strain and plated onto 7H10 with 20µg/ml of streptomycin. The complementation was 
confirmed by PCR.   
 
Statistical analysis   
Statistical analysis was performed on at least three independent experiments using 
GraphPad Prism 5.0 software and One-way ANOVA with Tukey’s post-test unless 
otherwise noted in the figure legends. Shown are representative results of triplicate 
values with standard deviation. The range of p-values is indicated as follows: * p=0.01< 




 4.4 Results and Discussion 
4.4.1 Identification of Anti-apoptotic Gene(s) from the M24 Cosmid Using Loss of 
Function Genetic Approaches 
Two large gene deletions from the M24 region were made in the Mtb strain 
H37Rv namely, ΔESX-5a (4 genes from esxI to pe8) and Δ25/26 (5 genes from fadD14 
to Rv1062) (refer to Fig 30). The gene deletions were confirmed by PCR for the 
deletion. The WT and two mutants were then used to infect THP-1 cells at an MOI 3:1. 
The cells were harvested 3dpi and levels of apoptosis was measured using the TUNEL 
assay. If the gene(s) of interest was deleted then that bacterial strain is expected to 
induce more cell death when compared to the WT infected cells. However, all the 
infected strains induced similar levels of apoptosis (10-15%) (Fig 31a). Thus, the above 
9 genes do not seem to have an anti-apoptotic function.  
The next approach was the LoGoF (Loss of- Gain of Function) screen using a 
panel of Mkan+ Tn::M24 clones. The genes with transposon (Tn) insertions in the M24 
cosmids were Rv1030 (kdpB), Rv1038c (esxJ) and Rv1028A (kdpF). The 3 strains in 
addition to WT and Mkan+M24 were infected into THP-1 cells at an MOI 3:1. The 
cells were harvested 3dpi and cell death was measured using TUNEL assay. The WT 
Mkan induced as high levels of apoptosis (~40%) as expected while the Mkan+M24 
induced approximately 15-20% apoptosis in THP-1 cells. If any one of those genes had 
an anti-apoptotic function then the transposon interruption of that gene in the cosmid 
would confer a loss of inhibition of apoptosis function to that transformant which would 





Figure 31: Identification of anti-apoptotic genes in the M24 cosmid. TUNEL assay 
done on THP-1 cells infected with (a) multiple gene knockouts of H37Rv or (b) Mkan WT and 
LoGoF strains. In each case the MOI is 3:1 and cells were harvested 3dpi. The figures is one 
representative experiment out of three. Statistical significance is indicated as * 0.01<p<0.05, 





However, all the clones with mutant M24 cosmids behaved like the WT M24 
transformant, showing that genes were not involved in apoptosis inhibition (Fig 31b). 
Since two genes from the kdp operon do not exhibit the function of interest, we ruled 
out the entire kdp operon from consideration bringing the total to 15 genes that did not 
have an anti-apoptotic function. 
The final loss of function approach was to use a host of Mtb single gene mutants. 
A ready library of transposon mutants made in a different clinical Mtb strain called 
CDC1551, was available from a repository called TARGET. THP-1 cells were infected 
with these CDC1551 transposon mutants at an MOI of 3:1 and the cells were harvested 
for a TUNEL assay 3dpi. The transposon insertions were in the genes Rv1045, Rv1048c 
and Rv1058. Out of the three Tn mutants, Tn::1048-542 showed significantly higher 
rate of apoptosis (~45-50%) when compared to WT CDC1551 infected cells (Fig 32a). 
To confirm that the pro-apoptotic phenotype of the mutant is due to abrogation of 
Rv1048c and not because of polar effects, a complement was generated. THP-1 cells 
were again infected with the Tn mutant, complement and WT Mtb as before. The anti-







Figure 32: Rv1048c is the anti-apoptotic gene from M24 cosmid. TUNEL assay was 
performed on THP1 cells infected with WT and (a) Tn mutants in CDC1551 background (b) 
Tn1048-542 mutant and complement. In each case the MOI is 3:1 and cells were harvested 
3dpi. The figures is one representative experiment out of three. Statistical significance is 






Induction of apoptosis benefits some pathogens such as Coxiella, Chlamydia 
and Yersinia as it helps to mitigate inflammatory responses while avoiding detection 
[23,118]. On the flip side, bacteria such as virulent Mtb prevent apoptosis induction, 
instead prefer pushing the cell death modality to necrosis as it helps with dissemination 
and infection spread [131]. Mtb is an intracellular pathogen that takes residence within 
the macrophages setting up its own replicative niche. To do so, it is known to inhibit 
multiple signaling events occurring during apoptosis such as secretion of soluble 
TNFR2 to neutralize TNF or manipulating the eicosanoid biosynthetic pathways. This 
inhibitory effect was seen only with virulent Mtb and not with avirulent strains such as 
Msme, Mkan and Mtb H37Ra [125].  
A gain of function genetic screen was conducted to identify the gene(s) 
responsible for apoptosis inhibition by transforming cosmids containing Mtb DNA 
fragments into Msme and Mkan [230]. As a result, the search was narrowed down to 
three non-overlapping DNA regions. The first anti-apoptotic gene to be identified from 
these three gene regions was nuoG. The M24 cosmid consists of 38 genes, many of 
which form operons and have a wide range of functions. Out of these, the genomic 
island region (Rv1041c to Rv1055) was of great interest because it is found exclusively 
in the Mtb complex. 
Different loss of function genetic approaches were used to identify the gene 
responsible for apoptosis inhibition. Firstly, a host of single gene transposon mutants 
of Mtb in the CDC1551 background were obtained. Secondly, the M24 cosmid was 
subjected to transposon mutagenesis and a library of mutant cosmids were generated. 
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These cosmids were transformed in to Mkan to perform a unique screen named as 
LoGoF. In this screen, the transformant has a mutant M24 cosmid with single gene 
interruption. Therefore, if the gene of interest was mutated, the the Mkan transformant 
would lose the ability to inhibit apoptosis and this clone would induce macrophage 
apoptosis at levels similar to WT Mkan. Both these screens target single genes which 
would not yield results in case functional redundancy between genes or the requirement 
of multiple gene to orchestrate the inhibitory effect. Therefore the third approach was 
used to generate multiple gene deletions mutants of Mtb H37Rv.  
While infecting THP-1 cells with the CDC1551 mutants at an MOI 3:1, it was 
seen that the loss of Rv1048c function caused significantly more apoptotic cell death 
than the WT infected cells as measured by TUNEL assay. To negate the possibility of 
polar effects in the mutant, a complement was generated. Upon THP-1 infection, the 
complement induced much lesser levels of apoptosis than the WT while the mutant 
went the other way showing that Rv1048c is responsible for the anti-apoptotic function 
(Fig 32a+ 32b).  
Following the identification of Rv1048c, it is important to characterize the function of 
this protein and understand how it affects host cell apoptosis inhibition. Rv1048c lies 
within the genomic island mentioned previously. It is designated as hypothetical 
protein and is highly conserved among members of the Mtb complex with homology 
greater than 85%. It is not found in any of the other mycobacterial species and does not 
share homology with any protein of known function. The protein has no known 
conserved domains offering very little clues as to how it could affect host cell pathways. 
Therefore, elucidating the subcellular location of this protein would help indicate if it 
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directly interacts with host cell effectors (upon export to bacterial cell surface or into 
the phagosome) or has indirect influence on the host signaling by regulating other 
bacterial effectors (cytoplasmic or membrane bound). Based on the analysis using 
programs such as signalP [177], the protein did not have any known signal sequences. 
The general secretion signal motif of T7SSs is YxxxD/E [55], which is absent in the 
Rv1048c protein. These factors indicate that Rv1048c is most likely to be retained 
intracellularly and indirectly affects host cell apoptosis. Rv1048c is found to be up-
regulated under certain stress conditions like high temperature [216] and in the 
presence of detergents [145,146]. Additionally, an analysis using the PHYRE2 
program shows that Rv1048c contains a region that shares homology with a “winged 
helix” DNA binding domain and multiple antibiotic resistance regulators (MarR) 
family of transcriptional regulators [126]. The MarR family reportedly regulate the 
expression of proteins conferring resistance to antibiotics, oxidative stress agents and 
some pathogenic factors [10]. Indeed, the bio-informatic data needs experimental 
validation and this can be done by assessing if Rv1048c can actually bind to DNA using 
assays such as ChIP (Chromatin Immunoprecipitation) assays followed by RNA 
sequencing. This would help in identifying the group of proteins whose expression 
Rv1048c regulates, a subset of which may directly influence the inhibition of host cell 
apoptosis.  
An interesting aspect that warrants further investigation is whether the function 
of Rv1048c as an anti-apoptotic effector is independent of previously identified genes 
such as nuoG, sodA etc. This question can be addressed by generating double mutants 
of Rv1048c with other genes. If this mutant induces more apoptosis in macrophages 
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when compared to the single mutants then the two gene products feed into independent 
pathways. This premise does make sense considering how the bacteria seem to 
modulate multiple host effectors (Fig 33).  
With the reemergence of Tb and the rise of drug resistant strains in the recent 
times, it is imperative that we update our arsenal of therapeutics against the disease. 
Understanding the mechanism of host cell apoptosis inhibition by Mtb will help 
identify new drug targets. Pro-apoptotic mutants are promising vaccine candidates as 
they tend to stimulate a faster and a more robust T-cell response. Identifying anti-
apoptotic genes that function independently could prove to be very useful for vaccine 
design, as multiple gene deletion mutants inducing higher rates of apoptosis could 








Figure 33:  Mechanisms of apoptosis inhibition by known Mtb anti-apoptotic 
proteins 
The figure describes the effects of various Mtb anti-apoptotic genes on host cell signaling 





CHAPTER 5: CONCLUSIONS AND FUTURE IMPLICATIONS 
 
In this dissertation we have described three major early evasion tactics 
employed by virulent Mtb to survive an onslaught by the host immune system. We have 
shown that Mtb inhibits Msme/dsDNA induced activation of the AIM2 inflammasome 
in an ESX-1 dependent manner (chapter 2). We also characterized the role of the ESX-
5a region in virulence, protein secretion and its effect on host cell processes (chapter 
3). In chapter 4, we describe the use of various loss of function genetic approaches to 
identify a novel anti-apoptotic gene (Rv1048c) from the M24 cosmid region. 
Inflammasome activation is a major innate immune response mounted by the 
host and can have several consequences on the survival of invading pathogens. It can 
lead to cell death by pyroptosis and/or onset of inflammation by the secretion of 
cytokines such as IL-1β and IL-18 [185]. Therefore, many pathogens have found ways 
to subvert the activation of inflammasomes (reviewed in section 1.3.4). In the case of 
infection with virulent Mtb, the only NLR responsible for secretion of IL-1β in infected 
macrophages and DCs is NLRP3 [1,128, 153]. However, our results show that avirulent 
mycobacterial species are also able to activate AIM2 (Fig 11a). This cytosolic receptor 
is known to indiscriminately bind to double-stranded DNA of microbial, viral, 
mammalian or synthetic origin [166, 183]. Pathogens such as F. tularensis and L. 
monocytogenes are known to activate the AIM2 inflammasome by accessing the host 
cytosol after infection. In the process, a few organisms die, resulting in the release of 
bacterial dsDNA into the cytosol [77, 119, 196]. Mtb on the other hand, are known to 
stay within the phagosome for several days after infection [108, 205] but still exports 
eDNA, quite early on, into the cytosol via its ESX-1 secretion system. The DNA sensor 
114 
 
IFI16/IFI204 detects the cytosolic eDNA which in turns leads to IFN-β production 
[147, 212]. However, we demonstrated that in spite of the presence of eDNA, the AIM2 
inflammasome was not activated.  Instead, Mtb actively inhibited the induction of 
AIM2 inflammasome by Msme infection or by transfection of artificial poly dA:dT in 
an ESX-1 dependent manner, implying that the secretion system was also involved in 
exporting the inhibitory factor (Fig 12).  
As in earlier reports with Francisella we found that IFN-β is required for the 
activation of AIM2 during Msme infection because there was a reduction in AIM2 
dependent IL-1β secretion in the presence of IFN-β neutralizing antibodies (Fig 11c). 
Based on these results, we hypothesized that the inhibition of IFN-β production is 
beneficial to the bacteria and this contradicts many earlier studies showing that the 
induction of a type I IFN signature actually leads to increased Mtb virulence 
[24,143,144, 147, 152, 212]. This was believed to be the case because IFN-β suppresses 
the activation of NLRP3 inflammasome and limits IL-1β secretion. The mechanism 
involves the induction of the anti-inflammatory cytokine, IL-10 by IFN-β signaling 
which in turn inhibits pro IL-1β production [152, 170]. However, none of these studies 
compared production of IFN-β in Mtb with other avirulent mycobacterial species, and 
indeed Mtb infected cells produced 20 fold less IFN-β when compared to the avirulent 
strains (Fig 11b). However, the inhibition is not complete as Mtb infection still induces 
some IFN-β production which in turn may be sufficient to limit NLRP3 dependent 
maturation of pro IL-1β and IL-18. Mtb was also able to reduce Msme- induced IFN-β 
secretion in an ESX-1 dependent manner. These results give rise to the possibility that 
Mtb inhibits AIM2 inflammasome activation indirectly by suppressing IFN-β 
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production and/or its downstream signaling. It has been reported that IFN-β increases 
aim2 transcription [120, 227]. However, we found no increase in levels of AIM2 
expression mirroring the results of another study with Francisella [77]. Instead, the 
point of inhibition lay at the level of caspase-1 activation by the inflammasome (Fig 
15). We also showed that exogenous addition of IFN-β did not completely reverse the 
inhibition of AIM2 inflammasome by Mtb (Fig 15c). Therefore, it seems more likely 
that there are multiple inhibitory mechanisms which interfere with the signaling events 
of both IFN-β and AIM2. 
The exact mechanism of inhibition still remains to be elucidated. A recent study 
has demonstrated that the mouse DNA sensor p202 has two (Hemopoeitic expression, 
Interferon-inducibility, Nuclear localization) HIN domains, of which only the HIN1 
domain binds to dsDNA while the HIN2 can dimerize with the AIM2’s HIN domain 
thereby preventing it from binding with dsDNA and activating the inflammasome 
[241]. Similarly, increased expression of another DNA sensor IFI16 (murine homolog- 
p204) was able to inhibit AIM2 inflammasome mediated caspase-1 activation [229]. 
Another group showed that an oligonucleotide containing the TTAGGG motif 
competed with cytosolic dsDNA to bind AIM2 and prevented further activation of the 
inflammasome [122] giving rise to possibility that Mtb eDNA may also contain certain 
inhibitory motifs. It would be interesting to see if Mtb exploits these mechanisms to its 
own advantage. It is also possible that one or several of the IFN-β regulated genes affect 
the activity of the AIM2 inflammasome. Since the inhibitory effect is ESX-1 
dependent, it will be conducive to identify IFN-β regulated genes that are differentially 
expressed upon infection with WT or ΔesxA Mtb by RNA sequencing technology or 
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qRT-PCR and see if any these targets are involved in AIM2 inflammasome dependent 
IL-1β secretion.  Another important avenue of investigation would be to identify which 
ESX-1 dependent Mtb effector mediates AIM2 inflammasome inhibition. The gain of 
function screen utilized previously to identify anti-apoptotic genes could also be used 
to pinpoint gene products that are involved in AIM2 inflammasome inhibition. Once 
narrowed down, loss of function genetic approaches can be used to identify the exact 
gene effector/s that inhibit the activation of AIM2.  
In chapter 3, we described the functions of a duplicated ESX region in protein 
secretion and its effect on virulence.  This four gene region termed as ESX-5a was 
duplicated from the esx/pe/ppe gene region of ESX-5 secretion system [96]. This region 
is involved in the secretion of ALD and a few other PE/PPE proteins via the parent 
ESX-5 system (Fig 18 to 21). Additionally, the EsxI and EsxJ proteins of the ESX-5a 
region are also secreted. On looking closely at its impact on the host immune system 
we found that deleting the Esx-5a region decreased the amount of secreted IL-1β by 
about 50% (Fig 23). A similar phenotype was seen in ESX-1 and ESX-5 mutants where 
the amounts of secreted IL-1β was reduced to background levels [2, 128]. Survival 
studies with the zebrafish model of infection show that the M.marinum ESX-5a mutant 
is attenuated (Fig 26) as it has been shown earlier with the Mtb ESX-5 mutant in mice 
[29, 197]. This result currently being confirmed in the mouse model with the Mtb 
ΔESX-5a. The above two results taken together may seem counterintuitive because it 
would be expected that both ESX-5 and ESX-5a mutants which limit IL-1β secretion 
ought to be more virulent, but in reality are highly attenuated. However, the secreted 
mycobacterial proteins execute various functions once exported into the host milieu to 
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help with bacterial survival and thus cannot avoid being detected by the host immune 
system, which leads to the subsequent induction of inflammation. Therefore, the 
bacteria secretes additional effectors to inhibit the inflammatory pathways (Fig 34) 
much like the YopK protein of Yersinia spp which is possibly secreted with the purpose 
of preventing the recognition of other Type III secreted factors by the NLRs and 
impairing inflammasome activation [35]. 
Identifying the role of ESX-5a in secretion of proteins via the ESX-5 system 
has led us to develop a model in which the other duplicated ESX regions are responsible 
for the export of various ESX-5 protein subsets and thus contribute to overall 
functioning of this secretion system (Fig 27). For example, ESX-5a deletion does not 
increase host cell death induction while the parent ESX-5 mutant has been shown to 
induce a late-stage caspase-independent death pathway [2].  It is possible that one of 
the other duplicated regions secrete effectors that mediate this phenotype. This 
hypothesis still requires experimental validation and if true, then the strain with 
deletions of all the duplicated regions would be more attenuated when compared to 
strains missing the individual regions. 
Studies in the future should include assays to decipher the function of ALD 
upon release into the host milieu and its contribution to virulence. Mtb ALD has a dual 
function as both an alanine dehydrogenase and a glycine dehydrogenase [97]. As a 
result there have been wide ranging suggestions about its actual function. ALD is 
shown to be important for peptidoglycan synthesis [43, 111], utilizing alanine during 





Figure 34: Overall effect of Mtb on inflammasome pathways 
(1) Inhibition of IFN-β (2) Inhibition of AIM2 inflammasome activation (3) Activation of 




ald mutants of B.subtilis and M.xanthus were defective for sporulation [207, 234]. All 
of these point to a role for ALD during latent infection thereby making it an attractive 
drug target. Raynaud et al, hypothesized that secreted ALD could convert alanine 
(abundantly present in the host cell) to pyruvate and generate ammonium as a by-
product which can then block phagosomal acidification [186]. This hypothesis can be 
tested by generating an ALD Mtb mutant and analyzing infected cells to see if the 
mutant is now unable to block acidification. Additionally, the ESX-5a mutant should 
also be tested to see if it prevents acidification of the phagosome, implying that 
secretion of ALD is also important for this phenotype. The ESX-5a genes can be 
utilized in the field of vaccine design. Members of the ESAT6 family are found to be 
highly immunogenic [119] and EsxJ was recently identified as an important CD8 T-
cell antigen [132]. Kaufmann and his colleagues have proposed an improved BCG 
vaccine candidate: BCG ΔureC::hly, which is urease deficient (urease prevents 
phagosomal acidification) and expresses listeriolysin O (LLO), a porin from L. 
monocytogenes that can perforate the phagosomal membrane at an acidic pH, allowing 
access to the host cytosol [100, 101]. This recombinant vaccine strain showed increased 
stimulation of CD4 T-cell response when compared to conventional BCG but the CD8 
T-cell population counts however, did not improve very much [63].  Potentially a BCG 
ΔureC::hly strain overexpressing esxI and esxJ can increase stimulation of CD8 T-cell 
populations and we could test its efficacy as a vaccine. 
Induction of host cell apoptosis is an important innate immune defense 
mechanism that provides the basis for other mechanisms such as- efferocytosis and 
cross-priming to stimulate T-cell mediated killing of pathogens [67, 149, 235]. Using 
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a gain of genetic screen, three Mtb genomic regions were identified as containing anti-
apoptotic genes [230]. Secondary loss of function genetic approaches were applied to 
the M24 region. We identified a novel anti-apoptotic gene: Rv1048c, adding to a 
growing list of anti-apoptotic genes (Fig 33). Rv1048c is an interesting gene with an 
unknown function and is contained on a genomic island, which is present only among 
the members of the virulent Mtb complex [18].  An investigation into the mechanism 
by which Rv1048c inhibits host cell apoptosis is required. It will be important to 
elucidate if Rv1048c directly interacts with host cell effectors to modulate the apoptotic 
response. If the effect happens to be indirect, then there could be other genes 
(potentially from the same genomic island) whose functions it regulates to orchestrate 
an anti-apoptotic phenotype. Therefore, it would be worthwhile to continue testing the 
remaining M24 genes for their ability to suppress apoptosis in macrophages.  
The results provided in this thesis have described several novel mechanisms 
employed by Mtb in an effort to modulate host innate immune responses and ensure its 
own survival. Despite the need for further investigation, these studies show promise of 
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